<SEC-DOCUMENT>0000049071-25-000055.txt : 20251105
<SEC-HEADER>0000049071-25-000055.hdr.sgml : 20251105
<ACCEPTANCE-DATETIME>20251105061116
ACCESSION NUMBER:		0000049071-25-000055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20251105
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251105
DATE AS OF CHANGE:		20251105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		ORGANIZATION NAME:           	02 Finance
		EIN:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		251451613

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hum-20251105.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:ac9ca574-edd9-47df-8fc9-1a02d1ef991b,g:b03f18ca-7daf-4a17-886f-cfdf6bfe8b15,d:bb47cc4d136449b2a87d57296682f7e8-->
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20251105</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20251105.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-05</xbrli:startDate><xbrli:endDate>2025-11-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibb47cc4d136449b2a87d57296682f7e8_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC&#160;20549</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.527%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 5, 2025</ix:nonNumeric> (November 5, 2025)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Humana Inc.</ix:nonNumeric> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.194%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.750%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-5975</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">500 West Main Street</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">KY</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">40202</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">502</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">580-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.472%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:36.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">HUM</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ibb47cc4d136449b2a87d57296682f7e8_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div id="ibb47cc4d136449b2a87d57296682f7e8_10"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Item&#160;7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended September 30, 2025, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.humana.com</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. Additionally, a copy of management's prepared remarks on the Company's financial results for the quarter ended September 30, 2025 and expectations for future earnings, is attached hereto as Exhibit 99.3, and incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ibb47cc4d136449b2a87d57296682f7e8_13"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits:</span></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.084%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:58.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-2025q38kxex99x1brief.htm">Press Release</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-2025q38kxex99x2detailed.htm">Earnings Release and Statistical Pages</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a3q2025humanaincpostedrema.htm">Prepared Management Remarks</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="6" style="padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ibb47cc4d136449b2a87d57296682f7e8_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.456%"><tr><td style="width:1.0%"/><td style="width:13.149%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.651%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">HUMANA INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">/s/ John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President, Chief Accounting Officer &amp; Controller</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Dated: November 5, 2025</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hum-2025q38kxex99x1brief.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic81a734313054cdab31786812a41748c_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:100%">n e w s</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:400;line-height:100%">  r e l e a s e</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 West Main Street</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.O. Box 1438</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Louisville, KY 40202</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.humana.com</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR MORE INFORMATION CONTACT&#58;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lisa Stoner<br>Humana Investor Relations<br>(502) 580-2652<br>e-mail&#58; LStamper&#64;humana.com</font></td><td colspan="3" style="padding:0 1pt;vertical-align:middle"><div style="text-align:center"><img alt="humanalogoa05.jpg" src="humanalogoa05.jpg" style="height:65px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mark Taylor</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Corporate Communications</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(317) 753-0345</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e-mail&#58; MTaylor108&#64;humana.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Humana Reports Third Quarter 2025 Financial Results&#59; </font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Affirms</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </font><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Full Year 2025 Adjusted EPS Guidance</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Reports 3Q25 earnings per share (EPS) of $1.62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a GAAP basis,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EPS of $3.24&#59; reports YTD EPS of $16.43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a GAAP basis, $21.10 on an Adjusted basis</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent'</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'&#59;  affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.02pt">Affirms</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.02pt">Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,000 members' compared to the previous guidance of a decline of 'up to 500,000 members'&#59; driven by stronger retention and better-than-expected sales</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Furthers the advancement of the company's long-term strategy through growth in the CenterWell and Medicaid businesses</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Actively preparing for the January 1, 2026 launch of the initial phase-in of the Michigan Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP) and the statewide Illinois Fully Integrated Dual Eligible Special Needs Plan (FIDE) programs, as well as the carve-in of dual eligibles into the South Carolina Medicaid program </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Growth of 56,600 patients, or nearly 15 percent, in CenterWell Primary Care as compared to December 31, 2024</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Continuation of strong CenterWell Pharmacy growth across payor agnostic offerings with increased Specialty volumes and strong Direct to Consumer growth, both exceeding previous expectations in 3Q25</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8&#58;00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">LOUISVILLE, KY (November 5, 2025)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Humana Inc. (NYSE&#58; HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated income before income taxes and equity in net losses (pretax results)</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">in millions</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2025&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2024&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Generally Accepted Accounting Principles (GAAP)</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$134</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$651&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$2,566</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,583&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with company's non-consolidating  minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">97</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">460</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">267</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">320</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(62)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(62)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$527</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$679&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3,437</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,998&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings per share (EPS)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2025&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2024&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1.62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3.98&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$16.43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15.72&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.37&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with company's non-consolidating  minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.80</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.49)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.81</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.17&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.27</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.63)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.05)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.54)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.80)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3.24</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4.16&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$21.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$18.35&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as  reconciliations.</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please refer to the tables above, as well as the consolidated and segment highlight sections in the detailed earnings release for additional discussion of the factors impacting the year-over-year quarterly and YTD comparisons.</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our strategy of putting the consumer at the heart of everything we do is working, with solid year to date performance and strong momentum heading into the Annual Election Period</font><font style="background-color:#ffffff;color:#212121;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; said Humana President and CEO Jim Rechtin. &#8220;</font><font style="background-color:#ffffff;color:#212121;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We feel positive about the direction we&#8217;re headed and the value we are creating for our members, patients and investors.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="margin-top:7pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="ic81a734313054cdab31786812a41748c_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">FY 2025 Earnings Guidance</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana revises its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) to 'approximately $12.26' from 'approximately $13.77', while affirming</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its Adjusted EPS guidance of 'approximately $17.00'. </font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:67.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><font><br></font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted earnings per share</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2025<br>&#160;Guidance</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$12.26</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.98&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.42</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.81</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.45&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of business (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.27</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.54)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.89)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP) &#8211; FY 2025 projected (b)&#59; FY 2024 reported</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$17.00</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.21&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations.</font></div><div style="padding-left:18pt;text-indent:-9pt"><font><br></font></div><div id="ic81a734313054cdab31786812a41748c_7"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Detailed Press Release</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana&#8217;s full earnings press release, including the statistical pages, has been posted to the company&#8217;s Investor Relations site and may be accessed at https&#58;&#47;&#47;humana.gcs-web.com&#47; or via a current report on Form 8-K filed by the company with the Securities and Exchange Commission this morning (available at www.sec.gov or on the company&#8217;s website).</font></div><div id="ic81a734313054cdab31786812a41748c_10"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Conference Call</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Humana will host a live question-and-answer session for analysts at 8&#58;00 a.m. Eastern time today to discuss its financial results for the quarter and the company&#8217;s expectations for future earnings. In advance of the question-and-answer session, Humana will post prepared management remarks to the Quarterly Results section of its Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A webcast of the 3Q25 earnings call may be accessed via Humana&#8217;s Investor Relations page at https&#58;&#47;&#47;humana.gcs-web.com&#47;.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">If you anticipate asking a question during the question-and-answer session, please register in advance at this link - https&#58;&#47;&#47;register-conf.media-server.com&#47;register&#47;BIbac7b49877b94c62a538fdf08464989c.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company suggests participants listening via the web or the conference call sign in or dial in at least 15 minutes in advance of the call. For those unable to participate in the live event, the virtual presentation archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page at https&#58;&#47;&#47;humana.gcs-web.com&#47;, approximately two hours following the live webcast.  </font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="ic81a734313054cdab31786812a41748c_13"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Footnotes</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has included financial measures throughout this earnings release that are not in accordance with GAAP. Management believes that these measures, when presented in conjunction with the corresponding GAAP measures, provide a comprehensive perspective to more accurately compare and analyze the company&#8217;s core operating performance over time. Consequently, management uses these non-GAAP (Adjusted) financial measures as consistent and uniform indicators of the company&#8217;s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Non-GAAP (Adjusted) financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. All financial measures in this earnings release are in accordance with GAAP unless otherwise indicated. Please refer to the footnotes for a detailed description of each item adjusted out of GAAP financial measures to arrive at non-GAAP (Adjusted) financial measures.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the periods covered in this earnings release, the following items are excluded from the non-GAAP financial measures described above, as applicable.  With the exception of the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Settlement of certain litigation expenses and Loss on sale of business </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjustments</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each of the adjustments described below also impacted FY 2024 Adjusted EPS as shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 3.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Amortization associated with identifiable intangibles -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since amortization varies based on the size and timing of acquisition activity, management believes this exclusion provides a more consistent and uniform indicator of performance from period to period. For all periods shown within this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results, EPS, and Insurance and CenterWell segments' income from operations. The table below discloses respective period amortization expense for each segment&#58;</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.916%"><tr><td style="width:1.0%"></td><td style="width:32.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amortization </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$9</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Put&#47;call valuation adjustments associated with the company&#8217;s non-consolidating minority interest investments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are the result of fair value measurements associated with the company's primary care strategic partnership and are unrelated to the company's core business operations.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results and EPS.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Value creation initiatives - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These charges relate to the company's ongoing initiative to drive additional value for the enterprise through cost saving, productivity initiatives, and value creation from previous investments, and primarily consist of asset impairment, severance charges, and external consulting spend specific to these initiatives. These charges were recorded at the corporate level and not allocated to the segments. For all periods shown within this earnings release, GAAP measures affected in this release include consolidated pretax results, EPS, and the consolidated operating cost ratio.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impact of exit of employer group commercial medical products business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts relate to activity from the exit of the employer group commercial medical products business as announced by Humana on February 23, 2023.  For all periods shown within this earnings release,</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results and </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally for 3Q24 and YTD 2024, additional impacted measures include&#58; consolidated revenues, consolidated benefit ratio, consolidated operating cost ratio, Insurance segment revenues, Insurance segment benefit ratio, Insurance segment operating cost ratio, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Settlement of certain litigation expenses - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relates to certain anticipated expenses the company accrued in connection with a legal matter.  For 3Q25 and YTD 2025, GAAP measures affected in this release include consolidated pretax results, EPS, the consolidated and Insurance segment operating cost ratios</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Loss on sale of business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disposition is not part of the company's ordinary course of operations and the impacts recognized from the disposal do not reflect core operational performance.  For 3Q25 and YTD 2025, GAAP measures affected in this release include consolidated pretax results and EPS. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impairment charges</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company recognized non-cash impairment charges related to certain indefinite-lived intangible assets based on the company's estimate of future financial performance in certain state markets. These charges were recorded at the corporate level and not allocated to the segments. For YTD 2025, GAAP measures affected in this release include consolidated pretax results, EPS, and the consolidated operating cost ratio.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Cumulative net tax impact - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment represents the cumulative net impact of the corresponding tax benefit or expense related to the aforementioned items excluded from the applicable GAAP measures. For 3Q25 and YTD 2025, the tax adjustment reflects the impact of the loss on sale business, which exceeded the book loss.  The related tax benefit is </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">realizable via capital loss carryback. For all periods presented in this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sole GAAP measure affected. </font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the reconciliations shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 2 of this release, the following are reconciliations of GAAP to Adjusted (non-GAAP) measures described above and disclosed within this earnings release&#58;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt;text-align:justify;text-indent:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenues</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,397</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,548</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,300</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,011</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:43.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,370</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,594</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,273</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,057</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Benefit ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED<br>Benefit ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT<br>Benefit ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Operating cost ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED<br>Operating cost ratio </font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.8)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.3)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT<br>Operating cost ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Insurance Segment - Income from operations</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income from operations </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$251</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$274</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,591</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,935</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$270</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$329</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,619</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,059</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b) FY 2025 GAAP EPS guidance and FY 2025 Adjusted (non-GAAP) EPS guidance exclude the impact of future value changes to items that have not yet been recognized. The company does not expect changes to its FY 2025 Adjusted (non-GAAP) EPS guidance.  The company does expect potential changes to its FY 2025 GAAP EPS guidance due to its ongoing value creation and other strategic initiatives. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div id="ic81a734313054cdab31786812a41748c_16"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;assumes,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58;  </font></div><div style="margin-bottom:2.4pt;padding-left:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient.  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The number of Humana&#8217;s Medicare Advantage plans rated 4-star or higher will significantly decline in 2025.  Humana filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, and on October 14, 2025, the Court issued a decision rejecting Humana's challenge. Although the company is considering its options in this matter, there can be no assurances that it will ultimately prevail in the lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and may also significantly adversely affect the company&#8217;s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability, including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a &#34;Fee for Service Adjuster&#34; could have a material adverse effect on the company's operating results, financial position and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana's business activities are subject to substantial government regulation.  New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected.  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company&#8217;s success, and its failure to do so could adversely affect the Company&#8217;s businesses, operating results and&#47;or future performance.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.    </font></div><div style="padding-left:36pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.  </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-K for the year ended December&#160;31, 2024&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-Q for the quarter ended March 31, 2025, June 30, 2025&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 8-Ks filed during 2025.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">About Humana </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Inc. is committed to putting health first &#8211; for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health &#8211; delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. </font></div><div><font><br></font></div><div id="ic81a734313054cdab31786812a41748c_19"></div><div style="margin-top:12pt"><font><br></font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>hum-2025q38kxex99x2detailed.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i351970ae9b8949ea83214dcf621a64d6_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.083%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n e w s  r e l e a s e</font></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:1pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.555%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.2</font></div></td></tr></table></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:125.25pt"><tr><td style="width:1.0pt"></td><td style="width:123.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:60pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">500 West Main Street</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.O. Box 1438</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Louisville, KY 40202</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.humana.com</font></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR MORE INFORMATION CONTACT&#58;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lisa Stoner<br>Humana Investor Relations<br>(502) 580-2652<br>e-mail&#58; LStamper&#64;humana.com</font></td><td colspan="3" style="padding:0 1pt;vertical-align:middle"><div style="text-align:right"><img alt="humanalogoa051.jpg" src="humanalogoa051.jpg" style="height:65px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"></div></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mark Taylor</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Humana Corporate Communications</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(317) 753-0345</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">e-mail&#58; MTaylor108&#64;humana.com</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Humana Reports Third Quarter 2025 Financial Results&#59; </font></div><div style="text-align:center"><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Affirms</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </font><font style="color:#5c9a1b;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Full Year 2025 Adjusted EPS Guidance </font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24&#59; reports YTD EPS of $16.43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a GAAP basis, $21.10 on an Adjusted basis</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent'</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'&#59;  affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.02pt">Affirms</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.02pt">Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,000 members' compared to the previous guidance of a decline of 'up to 500,000 members'&#59; driven by stronger retention and better-than-expected sales</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.02pt">Furthers the advancement of the company's long-term strategy through growth in the CenterWell and Medicaid businesses</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Actively preparing for the January 1, 2026 launch of the initial phase-in of the Michigan Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP) and the statewide Illinois Fully Integrated Dual Eligible Special Needs Plan (FIDE) programs, as well as the carve-in of dual eligibles into the South Carolina Medicaid program </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Growth of 56,600 patients, or nearly 15 percent, in CenterWell Primary Care as compared to December 31, 2024</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.59pt">Continuation of strong CenterWell Pharmacy growth across payor agnostic offerings with increased Specialty volumes and strong Direct to Consumer growth, both exceeding previous expectations in 3Q25</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8&#58;00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">LOUISVILLE, KY (November 5, 2025)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Humana Inc. (NYSE&#58; HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.</font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated income before income taxes and equity in net losses (pretax results)</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">in millions</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2025&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2024&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Generally Accepted Accounting Principles (GAAP)</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$134</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$651&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$2,566</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,583&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with company's non-consolidating  minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">97</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">460</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">267</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">320</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(62)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(62)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$527</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$679&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3,437</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,998&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.725%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings per share (EPS)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2025&#160;(a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2024&#160;(a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1.62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3.98&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$16.43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15.72&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.37&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with company's non-consolidating  minority interest investments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.80</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.49)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.81</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.17&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.27</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative net tax impact of non-GAAP adjustments</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.63)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.05)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.54)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.80)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3.24</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4.16&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$21.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$18.35&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as  reconciliations.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Please refer to the tables above, as well as the consolidated and segment highlight sections that follow for additional discussion of the factors impacting the year-over-year quarterly and YTD comparisons. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Our strategy of putting the consumer at the heart of everything we do is working, with solid year to date performance and strong momentum heading into the Annual Election Period</font><font style="background-color:#ffffff;color:#212121;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221; said Humana President and CEO Jim Rechtin. &#8220;</font><font style="background-color:#ffffff;color:#212121;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We feel positive about the direction we&#8217;re headed and the value we are creating for our members, patients and investors.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;</font></div><div id="i351970ae9b8949ea83214dcf621a64d6_13"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">FY 2025 Earnings Guidance</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana revises its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) to 'approximately $12.26' from 'approximately $13.77', while affirming</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">its Adjusted EPS guidance of 'approximately $17.00'. Additional FY 2025 guidance points are included on page</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14 of this earnings release.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-right:-11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.305%"><tr><td style="width:1.0%"></td><td style="width:65.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><font><br></font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted earnings per share</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2025<br>&#160;Guidance</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY 2024 (a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$12.26</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.98&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.42</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put&#47;call valuation adjustments associated with the company's non-consolidating minority interest investments (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.81</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.45&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.65</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.52)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of business (b)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.52</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges (b)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.27</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative net tax impact</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.54)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.89)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP) &#8211; FY 2025 projected (b)&#59; FY 2024 reported</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">approximately <br>$17.00</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.21&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well</font></div><div style="padding-left:27pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">as reconciliations.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div id="i351970ae9b8949ea83214dcf621a64d6_19"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana Consolidated Highlights</font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Humana Inc. Summary of Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions, except per share amounts)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024 (a)</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$29,397</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$88,548</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$29,300</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$88,011</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pretax results</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$134</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$651</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$2,566</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$2,583</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pretax results - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$527</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$679</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$3,437</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$2,998</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EPS </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$1.62</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$3.98</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$16.43</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$15.72</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EPS - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$3.24</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$4.16</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$21.10</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$18.35</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefit ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating cash flows</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$2,573</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$3,494</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Parent company cash and short term investments</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$1,940</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$609</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Debt-to-total capitalization</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">40.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42.3&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Days in claims payable (DCP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">33.2</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40.7</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div id="i351970ae9b8949ea83214dcf621a64d6_25"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Revenues</font></div><div style="margin-top:7pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">favorable</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> year-over-year quarterly and YTD GAAP consolidated revenues comparisons were primarily driven by the following factors&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher per member</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Medicare and state-based contracts premiums, with the Medicare increase largely driven by an increased direct subsidy due to the Inflation Reduction Act (IRA), and </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">membership growth in the company's state-based contracts and stand-alone PDP businesses.  </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the membership decline within the individual Medicare Advantage business, inclusive of the company's decision to exit certain unprofitable plans and counties.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated revenues for the respective periods. </font></div><div id="i351970ae9b8949ea83214dcf621a64d6_31"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Benefit Ratio</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year increase in the quarterly and YTD GAAP consolidated benefit ratios primarily reflected the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a shift in line of business mix resulting from </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">growth in the state-based contracts and stand-alone PDP businesses, which carry a higher benefit ratio, combined with a </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">reduction in individual Medicare Advantage membership, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">incremental investments to improve member and patient outcomes and support operational excellence.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, the year-over-year quarterly comparison was negatively impacted in 3Q25 as a result of the change in Medicare Part D seasonality due to the IRA.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">These factors were partially offset by the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">individual Medicare Advantage pricing inclusive of plan exits and benefit design changes, which more than offset claims trend and the funding environment, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher favorable prior period medical claims reserve development (prior period development) in 3Q25 and YTD 2025, the majority of which was anticipated.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year YTD comparison was further affected by the favorable workday impact in YTD 2025 combined with favorability associated with the change in Medicare Part D seasonality due to the IRA. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated benefit ratios for the respective periods. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Prior Period Medical Claims Reserve Development (Prior Period Development)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.888%"><tr><td style="width:1.0%"></td><td style="width:19.018%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.018%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.018%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Consolidated Favorable Prior Period Development</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">$ in millions</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Basis points (bps)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">First<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Second<br>Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Third Quarter</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">YTD</font></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prior Period Development from prior years recognized in 2025</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$477</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$161</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$275</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$913</font></td></tr><tr><td colspan="9" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Decrease to GAAP benefit ratio</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(160 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(90 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(100 bps)</font></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prior Period Development from prior years recognized in 2024 </font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$535</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$134</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$24</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$693</font></td></tr><tr><td colspan="9" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Decrease to GAAP benefit ratio</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(190 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(10 bps)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(80 bps)</font></td></tr></table></div><div id="i351970ae9b8949ea83214dcf621a64d6_37"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year increases in the quarterly and YTD GAAP consolidated operating cost ratios from the respective 2024 periods primarily resulted from the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">business mix changes, including within the CenterWell segment which runs a significantly higher operating cost ratio than the Insurance segment, </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">the operating leverage impact associated with the loss of individual Medicare Advantage membership, and</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">the impact of charges associated with the company's value creation initiatives, primarily related to severance in connection with workforce optimization and external consulting spend. These value creation initiative charges were recorded at the corporate level and not allocated to the segments. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This was partially offset by the following items&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives,</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">operating leverage associated with </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">increased revenues from the impact of the IRA as described above.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) consolidated operating cost ratios for the respective periods. </font></div><div id="i351970ae9b8949ea83214dcf621a64d6_43"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Balance sheet</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Days in claims payable (DCP) of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33.2</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> days at September 30, 2025 represented a de</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">crease</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of 3.3 days</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from 36.5 days at June 30</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2025</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and a decrease of 7.5</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days from 40.7 days at September 30, 2024. </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The sequential decline was primarily impacted by a reduction in claims processed but not yet paid, as well as lower reserve requirements in provider-capitation accruals, including the impact of payments to providers during 3Q25 in accordance with the respective risk-sharing arrangements (inclusive of the payout of the mid-year Medicare Risk Adjustment settlement). These reductions lowered the DCP metric by approximately 3 days and are generally timing in nature and not related to claims reserve levels. </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The year-over-year comparison was primarily impacted by the same factors affecting the sequential comparison with reductions in claims processed but not yet paid and provider-capitation accruals, together lowering the metric by approximately 5 days. As stated above, these items are generally timing in nature and not related to claims reserve levels.</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The year-over-year comparison was further impacted by an increased proportion of Medicare prescription drug benefit expense in 2025 as a result of structural changes associated with the IRA. Pharmacy claims are processed more quickly than medical claims leading to a lower DCP. This change accounted for the remaining decrease to the September 30, 2025 metric.  </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The total estimate of benefits payable for claims incurred but not reported (IBNR) included in the benefits payable line of the balance sheet as of September 30, 2025 was largely stable to the IBNR balance as of June 30, 2025 and September 30, 2024. </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana's debt-to-total capitalization at September 30</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">, 2025 de</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">creased 40 basis points to 40.3 percent fro</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">m 40.7 p</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">ercent at June 30</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">, 2025 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">primarily driven </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">by the impact of 3Q25 earnings.</font></div><div id="i351970ae9b8949ea83214dcf621a64d6_49"></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Operating cash flows</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">YTD 2025 GAAP operating cash flows decreased from the YTD 2024 period primarily reflecting the unfavorable impact of working capital items, partially offset by higher GAAP net income in YTD 2025.</font></div><div id="i351970ae9b8949ea83214dcf621a64d6_64"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana&#8217;s Insurance Segment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This segment is comprised of insurance products serving Medicare and state-based contract beneficiaries, as well as individuals and employers. The segment also includes the company's Pharmacy Benefit Manager, or PBM, business.   </font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance Segment Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2025 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2024 (a)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,370</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,594</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,273</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,057</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$251</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$274</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,591</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,935</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$270</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$329</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,619</font></td><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,059</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment Revenues</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year i</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ncreases</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the quarterly and YTD GAAP segment revenues from the respective 2024 periods primarily reflected the following items&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher per member</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Medicare and state-based contracts premiums, with the Medicare increase largely driven by an increased direct subsidy due to the IRA, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">membership growth in the company's state-based contracts and stand-alone PDP businesses. </font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the membership decline within the individual Medicare Advantage business, inclusive of the company's decision to exit certain unprofitable plans and counties.</font></div><div style="margin-top:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment revenues for the respective periods. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment Benefit Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The year-over-year increase in the quarterly GAAP segment benefit ratio primarily reflected the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a shift in line of business mix resulting from </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">growth in the state-based contracts and stand-alone PDP businesses, which carry a higher benefit ratio, combined with a </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">reduction in individual Medicare Advantage membership, and </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">incremental investments to improve member and patient outcomes and support operational excellence.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, the year-over-year quarterly comparison was negatively impacted in 3Q25 as a result of the change in Medicare Part D seasonality due to the IRA. </font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">These factors were partially offset by the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">individual Medicare Advantage pricing inclusive of plan exits and benefit design changes, which more than offset claims trend and the funding environment, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">higher favorable prior period development in 2025, the majority of which was anticipated.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year decline of the YTD 2025 GAAP segment benefit ratio from the YTD 2024 ratio resulted from the net favorable impact of the factors impacting the quarterly comparison as described above. The year-over-year YTD comparison was further affected by the favorable workday impact in YTD 2025 combined with favorability associated with the change in Medicare Part D seasonality due to the IRA. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment benefit ratios for the respective periods.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Insurance Segment Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The modest year-over-year decreases in the quarterly and YTD GAAP segment operating cost ratios from the respective 2024 periods primarily related to the following&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives, and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">operating leverage associated with increased revenues from the impact of the IRA as described above.  </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the operating leverage impact of the loss of individual Medicare Advantage membership. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for a reconciliation of GAAP to Adjusted (non-GAAP) Insurance segment operating cost ratios for the respective periods. </font></div><div id="i351970ae9b8949ea83214dcf621a64d6_76"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Humana&#8217;s CenterWell Segment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This segment includes pharmacy (excluding the PBM operations), primary care, and home solutions. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and&#47;or lower drug costs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell Segment Results</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$5,879</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,041</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,511</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,806</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$305</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$382</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,041</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,002</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP) (c)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$358</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$439</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,213</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,168</font></td></tr></table><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">CenterWell Segment Revenues</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The favorable year-over-year quarterly and YTD CenterWell GAAP segment revenues comparisons were primarily driven by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">higher revenues associated with growth in the company's pharmacy and primary care businesses, partially offset by the impact of the v28 risk model revision. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">CenterWell Segment Operating Cost Ratio</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The year-over-year</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> increases i</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n the segment's GAAP quarterly and YTD operating cost ratios primarily resulted from the following&#58;</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">continued phase-in of the v28 risk model revision within the company's primary care business, and</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">the uptick of volume within CenterWell Specialty Pharmacy, which carries a higher operating cost ratio than the traditional pharmacy business. </font></div><div style="margin-top:12pt;padding-left:13.5pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These factors were partially offset by the following&#58;</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">more favorable operating trends in the primary care business as a result of the maturation of the company's v28 mitigation activities, and</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">administrative cost efficiencies resulting from the company's value creation initiatives.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See additional operational metrics for the CenterWell segment on pages S-13 through S-15 of the statistical supplement included in this earnings release.</font></div><div id="i351970ae9b8949ea83214dcf621a64d6_82"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Conference Call</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Humana will host a live question-and-answer session for analysts at 8&#58;00 a.m. Eastern time today to discuss its financial results for the quarter and the company&#8217;s expectations for future earnings. In advance of the question-and-answer session, Humana will post prepared management remarks to the Quarterly Results section of its Investor Relations page (https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A webcast of the 3Q25 earnings call may be accessed via Humana&#8217;s Investor Relations page at https&#58;&#47;&#47;humana.gcs-web.com&#47;.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">If you anticipate asking a question during the question-and-answer session, please register in advance at this link - https&#58;&#47;&#47;register-conf.media-server.com&#47;register&#47;BIbac7b49877b94c62a538fdf08464989c.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company suggests participants listening via the web or the conference call sign in or dial in at least 15 minutes in advance of the call. For those unable to participate in the live event, the virtual presentation archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page at https&#58;&#47;&#47;humana.gcs-web.com&#47;, approximately two hours following the live webcast.  </font></div><div id="i351970ae9b8949ea83214dcf621a64d6_85"></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Footnotes</font></div><div style="margin-top:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has included financial measures throughout this earnings release that are not in accordance with GAAP. Management believes that these measures, when presented in conjunction with the corresponding GAAP measures, provide a comprehensive perspective to more accurately compare and analyze the company&#8217;s core operating performance over time. Consequently, management uses these non-GAAP (Adjusted) financial measures as consistent and uniform indicators of the company&#8217;s core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Non-GAAP (Adjusted) financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. All financial measures in this earnings release are in accordance with GAAP unless otherwise indicated. Please refer to the footnotes for a detailed description of each item adjusted out of GAAP financial measures to arrive at non-GAAP (Adjusted) financial measures.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the periods covered in this earnings release, the following items are excluded from the non-GAAP financial measures described above, as applicable.  With the exception of the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Settlement of certain litigation expenses and Loss on sale of business </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjustments</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each of the adjustments described below also impacted FY 2024 Adjusted EPS as shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 3.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Amortization associated with identifiable intangibles -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since amortization varies based on the size and timing of acquisition activity, management believes this exclusion provides a more consistent and uniform indicator of performance from period to period. For all periods shown within this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results, EPS, and Insurance and CenterWell segments' income from operations. The table below discloses respective period amortization expense for each segment&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.916%"><tr><td style="width:1.0%"></td><td style="width:32.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amortization </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$13</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$9</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$30</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33</font></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Put&#47;call valuation adjustments associated with the company&#8217;s non-consolidating minority interest investments - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are the result of fair value measurements associated with the company's primary care strategic partnership and are unrelated to the company's core business operations.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods shown within this earnings release, GAAP measures affected include consolidated pretax results and EPS.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Value creation initiatives - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These charges relate to the company's ongoing initiative to drive additional value for the enterprise through cost saving, productivity initiatives, and value creation from previous investments, and primarily consist of asset impairment, severance charges, and external consulting spend specific to these initiatives. These charges were recorded at the corporate level and not allocated to the segments. For all periods shown within this earnings release, GAAP measures affected in this release include consolidated pretax results, EPS, and the consolidated operating cost ratio.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impact of exit of employer group commercial medical products business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts relate to activity from the exit of the employer group commercial medical products business as announced by Humana on February 23, 2023.  For all periods shown within this earnings release,</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP measures affected include consolidated pretax results and </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS.</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally for 3Q24 and YTD 2024, additional impacted measures include&#58; consolidated revenues, consolidated benefit ratio, consolidated operating cost ratio, Insurance segment revenues, Insurance segment benefit ratio, Insurance segment operating cost ratio, and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Settlement of certain litigation expenses - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relates to certain anticipated expenses the company accrued in connection with a legal matter.  For 3Q25 and YTD 2025, GAAP measures affected in this release include consolidated pretax results, EPS, the consolidated and Insurance segment operating cost ratios</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Insurance segment income from operations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Loss on sale of business - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disposition is not part of the company's ordinary course of operations and the impacts recognized from the disposal do not reflect core operational performance.  For 3Q25 and YTD 2025, GAAP measures affected in this release include consolidated pretax results and EPS. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Impairment charges</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The company recognized non-cash impairment charges related to certain indefinite-lived intangible assets based on the company's estimate of future financial performance in certain state markets. These charges were recorded at the corporate level and not allocated to the segments. For YTD 2025, GAAP measures affected in this release include consolidated pretax results, EPS, and the consolidated operating cost ratio.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.02pt">Cumulative net tax impact - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment represents the cumulative net impact of the corresponding tax benefit or expense related to the aforementioned items excluded from the applicable GAAP measures. For 3Q25 and YTD 2025, the tax adjustment reflects the impact of the loss on sale business, which exceeded the book loss.  The related tax benefit is realizable via capital loss carryback. For all periods presented in this earnings release, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the sole GAAP measure affected.  </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the reconciliations shown on</font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">page 2 of this release, the following are reconciliations of GAAP to Adjusted (non-GAAP) measures described above and disclosed within this earnings release&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenues</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,397</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,548</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,300</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,011</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:43.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Revenues </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,370</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,594</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(537)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,273</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,057</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;text-align:justify;text-indent:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Benefit ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED<br>Benefit ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:44.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.546%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT<br>Benefit ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Operating cost ratio </font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:44.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONSOLIDATED<br>Operating cost ratio </font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value creation initiatives</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.8)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.3)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT<br>Operating cost ratio</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.1)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#def3c0;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Insurance Segment - Income from operations</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income from operations </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$251</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$274</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,591</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,935</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization associated with identifiable intangibles</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of certain litigation expenses</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of exit of employer group commercial medical products business</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$270</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$329</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,619</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,059</font></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b) FY 2025 GAAP EPS guidance and FY 2025 Adjusted (non-GAAP) EPS guidance exclude the impact of future value changes to items that have not yet been recognized. The company does not expect changes to its FY 2025 Adjusted (non-GAAP) EPS guidance.  The company does expect potential changes to its FY 2025 GAAP EPS guidance due to its ongoing value creation and other strategic initiatives. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c) The CenterWell segment Adjusted income from operations includes an adjustment to add back depreciation and amortization expense to the segment's GAAP income from operations since such an adjustment is commonly utilized for valuation purposes within the healthcare delivery industry. </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%">  </font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:43.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CENTERWELL SEGMENT </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Income from operations </font></div><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q25</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3Q24</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$305</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$382</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,041</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,002</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$358</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$439&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,213</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,168&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div id="i351970ae9b8949ea83214dcf621a64d6_97"></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;assumes,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements.  </font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58;  </font></div><div style="margin-bottom:2.4pt;padding-left:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana's reserves may be insufficient.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.53pt">The number of Humana&#8217;s Medicare Advantage plans rated 4-star or higher will significantly decline in 2025.  Humana filed a lawsuit seeking to set aside and vacate the 2025 Star Ratings of its Medicare Advantage plans, and on October 14, 2025, the Court issued a decision rejecting Humana's challenge. Although the company is considering its options in this matter, there can be no assurances that it will ultimately prevail in the lawsuit. If the company is not successful, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS and may also significantly adversely affect the company&#8217;s revenues, operating results, and cash flows. In addition, there can be no assurances the company will be successful in maintaining or improving its Star Ratings in future years. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the company's operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability, including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a &#34;Fee for Service Adjuster&#34; could have a material adverse effect on the company's operating results, financial position and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana's business activities are subject to substantial government regulation.  New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.53pt">Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the Company&#8217;s success, and its failure to do so could adversely affect the Company&#8217;s businesses, operating results and&#47;or future performance.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Volatility or disruption in the securities and credit markets may significantly and adversely affect the value of our investment portfolio and the investment income that we derive from this portfolio.    </font></div><div style="padding-left:36pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.  </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58; </font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-K for the year ended December&#160;31, 2024&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 10-Q for the quarter ended March 31, 2025, June 30, 2025&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">Form 8-Ks filed during 2025.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">About Humana </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Humana Inc. is committed to putting health first &#8211; for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health &#8211; delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_100"></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"></td><td style="width:21.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%;text-decoration:underline">Humana Inc. Full Year 2025 Projections - As of November 5, 2025</font></td></tr><tr style="height:3pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted earnings per common share (EPS)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">As of 3Q25 Earnings</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">As of 2Q25 Earnings</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">approximately $12.26</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">approximately $13.77</font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> approximately $17.00</font></div></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Total Revenues</font></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at least $128 billion</font></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and segment level revenue projections include expected investment income.<br>Segment level revenues include amounts that eliminate in consolidation.</font></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Insurance segment</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at least $123 billion</font></div></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CenterWell segment</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at least $21.5 billion</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Change in year-end medical membership from prior year-end</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Decline of approximately 425,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Decline of 'up to 500,000'</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Relatively flat</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Growth of approximately 200,000</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State-based contracts</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Growth of approximately 160,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Growth within 175,000 to 250,000 range</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, Virginia, and Wisconsin.</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Benefit Ratio</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Insurance segment</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 90.1% to 90.5%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ratio calculation&#58; benefits expense as a percent of premiums revenues.</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Operating Cost Ratio </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">            Consolidated</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6% to 12.1%</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3% to 11.7%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3% to 11.7%</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ratio calculation&#58; operating costs excluding depreciation and amortization as a percent of revenues excluding investment income.<br></font><font style="font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due to charges incurred to date and charges that could potentially be recorded related to the company's ongoing value creation and other strategic initiatives, the company anticipates potential changes to its FY 2025 GAAP ratio. </font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Segment Results</font></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Insurance segment income from operations</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$1.6 billion to $2.0 billion</font></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;<br></font><font style="font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization.</font></td></tr><tr style="height:50pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CenterWell segment income from operations</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> $1.1 billion to $1.5 billion</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> $1.3 billion to $1.7 billion</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Effective Tax Rate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  approximately 20.0%</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  approximately 25.0%</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  approximately 25.0%</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Weighted Avg. Share Count for Diluted EPS</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">approximately 121 million</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash flows from operations</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GAAP&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> $2.4 billion to $2.9 billion</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Capital expenditures</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no change</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">approximately $650 million</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_106"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Statistical Schedules</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">Supplementary Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:40pt;font-weight:400;line-height:120%">3Q25 Earnings Release</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-1</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_109"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.833%"><tr><td style="width:1.0%"></td><td style="width:23.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Humana Inc.<br>Statistical Schedules and Supplementary Information <br>3Q25 Earnings Release  </font></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Summary of Results - Consolidated and Segments - Quarter &#38; YTD</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Statements of Income - Quarter &#38; YTD</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-6)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows - YTD</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-7) - (S-8)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidating Statements of Income - Quarter</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-9) - (S-10)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidating Statements of Income - YTD</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-11) </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Membership Detail</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-12)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Premiums and Services Revenue Detail</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-13) - (S-15)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CenterWell Segment - Pharmacy Solutions, Primary Care, &#38; Home Solutions</font></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(S-16)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Footnotes</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-2</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_115"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.270%"><tr><td style="width:1.0%"></td><td style="width:41.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#5c9a1b;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Humana Inc. Summary of Results<br></font><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions, except per share amounts)</font></div></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q25 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3Q24 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2025 (a)</font></td><td colspan="3" style="background-color:#5c9a1b;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YTD 2024 (a)</font></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONSOLIDATED</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,397</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,548</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$32,649</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,300</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$97,149</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$88,011</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax results</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$134</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$651</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,566</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,583</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax results - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$527</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$679</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$3,437</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,998</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS </font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1.62</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.98</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16.43</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.72</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$3.24</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.16</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$21.10</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.35</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,573</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,494</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent company cash and short term investments</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,940</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$609</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt-to-total capitalization</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days in claims payable (DCP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.2</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INSURANCE SEGMENT</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,370</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,594</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$31,189</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,273</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$93,220</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$85,057</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#def3c0;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#def3c0;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio - Adjusted (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$251</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$274</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,591</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,935</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$270</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$329</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,619</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,059</font></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CENTERWELL SEGMENT</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$5,879</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,041</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,511</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,806</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</font></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$305</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$382</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,041</font></td><td colspan="3" style="background-color:#def3c0;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,002</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations - Adjusted (non-GAAP) (c)</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$358</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$439</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,213</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,168</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Refer to the &#34;Footnotes&#34; section included in the previous narrative portion of this release (beginning on page 8) for further explanation of disclosures for </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Adjusted (non-GAAP) financial measures, as well as reconciliations.</font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidated Statements of Income (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except per common share results</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.229%"><tr><td style="width:1.0%"></td><td style="width:43.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.371%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended&#160;<br>September 30,</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For&#160;the&#160;nine months ended <br>September 30,</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Premiums</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">30,711</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27,951&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">91,941</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84,354&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Services</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,600</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4,334</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,265&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">338</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">343&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">874</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">929&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">32,649</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29,397&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">97,149</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88,548&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">27,991</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,120&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">82,091</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75,283&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4,085</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,339&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11,012</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,529&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">173</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">534</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">631&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">32,249</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28,669&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">93,637</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85,443&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Income from operations</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">400</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">728&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3,512</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,105&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">168</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">169&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">485</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">496&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other expense (income), net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(92)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">398</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Income before income taxes and equity in net losses</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">134</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">651&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2,566</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,583&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Benefit) provision from income taxes</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(86)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">499</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">629&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity in net losses (A)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(26)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(16)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(88)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(57)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">194</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">480&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,979</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,897&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interests</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Net income attributable to Humana</font></td><td style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">195</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">480&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1,984</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,900&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic earnings per common share</font></td><td style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.99&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.47</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.76&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Diluted earnings per common share</font></td><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.98&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.72&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic earnings per common share (000&#8217;s)</font></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,273</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,405&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,492</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,609&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing diluted earnings per common share (000&#8217;s)</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,745</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,764&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120,778</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,899&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-4</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_121"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except share amounts</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.062%"><tr><td style="width:1.0%"></td><td style="width:72.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.023%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December&#160;31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,388</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,736</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,684</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,704&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,944</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,676&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,752</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,815&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,268</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,532&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">440</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">421&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity method investments</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">623</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">697&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,619</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,631&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,017</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</font></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49,719</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,479&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefits payable</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,088</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,440&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,519</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,259&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book overdraft</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">308</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">403&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenues</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">265</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">260&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,180</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,939&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,607</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,144&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,350</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,951&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31,137</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,034&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $1 par&#59; 10,000,000 shares authorized, none issued</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#242424;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $0.16 2&#47;3 par&#59; 300,000,000 shares authorized&#59; 198,719,321 issued at September 30, 2025</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital in excess of par value</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,639</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,463&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">29,980</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,317&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(666)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,067)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#242424;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost, 78,446,253 shares at September 30, 2025</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14,464)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,371)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,522</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,375&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">60</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total equity</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,582</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,445&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities and equity</font></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49,719</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,479&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt-to-total capitalization ratio</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">40.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.9&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-5</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_124"></div><hr style="page-break-after:always"><div style="min-height:31.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows (Unaudited) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.979%"><tr><td style="width:1.0%"></td><td style="width:66.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.965%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For&#160;the nine months ended September  30,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,979</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,897&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on sale of business</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">63</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on investment securities, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(66)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in net losses</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">88</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">193</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">587</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">682&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">43</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of property and equipment</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of indefinite-lived intangible assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of businesses acquired and disposed&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivables</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(109)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,374)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefits payable</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(351)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">884&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,317</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(498)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned revenues</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(71)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">27</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,573</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,494&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of business, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">115</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions, net of cash and cash equivalents acquired</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(344)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in securities lending collateral receivable</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(141)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(361)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5,198)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,042)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturities of investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,148</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of investment securities</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,066</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,758&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,641</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,889)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments from contract deposits, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,164)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(638)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,481</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,232&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of senior notes</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(771)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(48)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments from issuance of commercial paper, net</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(895)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issue costs</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in book overdraft</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(95)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(109)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(768)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(321)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(323)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in securities lending payable</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">141</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in rebate factor payable</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(123)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net </font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(76)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,047)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(183)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,167</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,221</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,694&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period </font></td><td style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,388</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,116&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-6</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_130"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the three months ended September 30, 2025 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,456&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,456&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,451&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,451&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,711&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,711&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,978&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,311&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,546&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,547)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,189&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,419)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,649&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,982&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,991&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,244)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,085&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,938&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,263)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,249&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the three months ended September 30, 2024 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,856&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,856&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,490&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,490&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other </font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,921&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,951&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,951&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,177&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,054&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,165)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,370&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,041&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,014)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,397&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,319&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,120&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,602&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,858)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,339&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,096&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,086)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,669&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the nine months ended September 30, 2025 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div style="margin-bottom:1pt;text-align:center;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.625%"><tr><td style="width:1.0%"></td><td style="width:44.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,901&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,901&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,822&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,822&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,647&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,647&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,757&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,757&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,941&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,941&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,666&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,275&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,905)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,220&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,511&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,582)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,149&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,278&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,091&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,900&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,298&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,186)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,012&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,629&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,470&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,462)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,637&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt"><font><br></font></div><div style="margin-bottom:1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Consolidating Statements of Income&#8212;For the nine months ended September 30, 2024 (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In millions</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.145%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eliminations&#47;<br>Corporate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues&#8212;external customers Premiums&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,519&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,519&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,840&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,840&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,768&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,768&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total premiums</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,354&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,354&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services revenue&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services and other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total services revenue</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues&#8212;external customers</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,069&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,619&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,256&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,259)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,594&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,806&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,852)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,548&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,752&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,283&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,354&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,638&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,463)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,529&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,659&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,804&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,020)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,443&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit ratio</font></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8&#160;</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating cost ratio</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-10</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_136"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Membership Detail  (Unaudited)     </font><font style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">In thousands</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.041%"><tr><td style="width:1.0%"></td><td style="width:36.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.199%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.204%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Members may not be unique to each product since members have the ability to enroll in more than one product.  </font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average 3Q25</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Membership&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Individual Medicare Advantage*</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,237.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,232.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,659.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,661.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">569.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">570.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">545.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,807.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,802.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,205.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,207.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,446.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,440.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,315.7&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,288.2&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,253.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,242.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,521.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,495.7&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">474.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">464.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">377.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State-based contracts and other</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,658.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,670.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,446.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,459.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Military services</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,605.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,605.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,984.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,009.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total excluding employer group commercial medical</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,992.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,983.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,309.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,342.0&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fully-insured commercial medical</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASO commercial</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total employer group commercial medical</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.3&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Medical Membership</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,992.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,983.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,358.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,347.1&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Membership&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dental&#8212;fully-insured (B)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,097.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,095.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,070.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,054.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dental&#8212;ASO</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">308.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">309.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Dental</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,406.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,404.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,361.9&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,355.8&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vision</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,911.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,912.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,846.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,843.6&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other supplemental benefits</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">392.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">390.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">362.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Specialty Membership</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,710.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,706.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,566.8&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,562.0&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Member Mix<br>September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Member Mix<br>September 30, 2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Individual Medicare Advantage Membership</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HMO</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,625.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,866.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPO&#47;PFFS</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,612.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,792.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Individual Medicare Advantage</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,237.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,659.2&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Individual Medicare Advantage Membership</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared Risk (C)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,939.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">37</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,111.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Path to Risk (D)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,613.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,873.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Value-based</font></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,553.0</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,984.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,684.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,674.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Individual Medicare Advantage</font></td><td colspan="2" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,237.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,659.2&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Individual Medicare Advantage membership includes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> 765,800 </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Dual Eligible Special Need Plans (D-SNP) members as of September 30, 2025, a net decrease of 173,800, or 18 percent, from 939,600 as of September 30, 2024, and down 171,300, or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18 percent</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, from 937,100 as of December 31, 2024.</font></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-11</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_139"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div id="i351970ae9b8949ea83214dcf621a64d6_145"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc. </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Premiums and Services Revenue Detail (Unaudited)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dollars in millions, except per member per month&#59; includes intersegment revenues </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.562%"><tr><td style="width:1.0%"></td><td style="width:28.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended&#160;<br>September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the nine months ended <br>September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Per&#160;Member&#160;per&#160;Month&#160;(I)<br>For&#160;the&#160;three&#160;months&#160;ended&#160;September 30,</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Per&#160;Member&#160;per&#160;Month&#160;(I)<br>For the nine months ended September 30,</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Insurance</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual Medicare Advantage</font></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22,456</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,856&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">67,901</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,519&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,431</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,443</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,322&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Group Medicare Advantage</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,240</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,913&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,822</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,840&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,310</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,166&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,326</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,183&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,755</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,924</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">240</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">225</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State-based contracts and other (E)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,729</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,921&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,757</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,756&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">708</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">653&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">702</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial fully-insured (F)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">N&#47;A</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">N&#47;A</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Specialty benefits (G)</font></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">248</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">738</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">283</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">799</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">203</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">203</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Military and other (H)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">268</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">728</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">674&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial ASO</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total </font></td><td colspan="2" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30,979</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,178&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">92,669</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,072&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CenterWell</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmacy solutions</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,430</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,933&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,409</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,635&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Primary care</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,564</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,462</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,666&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Home solutions </font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">885</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,640</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,505&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,879</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,041&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16,511</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,806&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Pharmacy Solutions (Unaudited)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.958%"><tr><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the&#160;three&#160;months&#160;ended<br>June 30, 2025</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Generic Dispense Rate</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">90.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">90.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">90.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mail-Order Penetration</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">25.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="padding-left:99pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.375%"><tr><td style="width:1.0%"></td><td style="width:28.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For&#160;the&#160;nine&#160;months&#160;ended September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">For&#160;the nine&#160;months&#160;ended<br>September 30, 2024</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Generic Dispense Rate</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">90.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mail-Order Penetration</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 49.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Medicare</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">25.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Primary Care (J) (Unaudited) </font></div><div><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.041%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of September 30, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">De novo</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">147&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">423</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106,200&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64,100&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43.4&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65.7&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Wholly-owned</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">195</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">769</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">266,400&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">181</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">658</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">217,300&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Independent Physician Associations</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62,800&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">342</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,192&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">447,100&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">301</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">953&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">344,200&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.6&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25.1&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.9&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.020%"><tr><td style="width:1.0%"></td><td style="width:17.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">YTD Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Primary</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Center</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Care</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Patients</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served (K)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Count</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Providers</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Served</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">De novo</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">133&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">327</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">79,400&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.4&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33.8&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Wholly-owned</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">211</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">675</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">246,500&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Independent Physician Associations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64,600&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">344</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,002&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">390,500&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.0&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:120%">CenterWell Segment - Home Solutions (Unaudited) </font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.145%"><tr><td style="width:1.0%"></td><td style="width:29.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the three months ended<br>September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the three months ended<br>September 30, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Episodic Admissions (L)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">78,248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">79,149&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">(1.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Total Admissions - Same Store (M)</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">106,628&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">103,356&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div style="margin-bottom:1pt;text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.145%"><tr><td style="width:1.0%"></td><td style="width:29.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the nine months ended<br>September 30, 2025</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">For the nine months ended<br>September 30, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Year-over-Year Growth</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Episodic Admissions (L)</font></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">239,154&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">244,433&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">(2.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Total Admissions - Same Store (M)</font></td><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">324,821&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">316,146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-15</font></div></div></div><div id="i351970ae9b8949ea83214dcf621a64d6_157"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Footnotes to Statistical Schedules and Supplementary Information</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3Q25 Earnings Release </font></div><div><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.87pt">Net losses associated with the company's non-consolidated minority interest investments.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.25pt">Fully-insured dental membership as reported does not include Humana members that have a Medicare Advantage plan that includes an embedded dental benefit. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">C.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:9.37pt">In certain circumstances, the company contracts with providers to accept financial risk for a defined set of Medicare Advantage membership. For these Downside Risk arrangements, the provider is measured against a medical expense ratio target and the company may share savings from reduction to the total cost of care of the defined membership. The result is a high level of engagement on the part of the provider. Under these arrangements, the company may contract with providers to accept partial, full, or global financial risk. In certain instances (capitated shared risk) of these arrangements, the company may choose to prepay these providers a monthly fixed-fee per member to coordinate substantially all of the medical care for their Medicare Advantage members assigned or attributed to their provider panel, including some health benefit administrative functions and claims processing.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">D.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.47pt">A Path to Risk provider is one who has a high level of engagement and has contracted with the company to participate in an Upside Only&#47;Shared Savings total cost of care arrangement and&#47;or in one of Humana&#8217;s Quality Bonus programs (Model Practice), through which the company rewards the provider for achieving quality and utilization targets. Providers who are contracted in an Upside Only&#47;Shared Savings arrangement may receive a portion of achieved surpluses when the actual cost of the medical services provided to patients assigned or attributed to their panel is less than the agreed upon medical expense targets. These contracts may also include a Downside Risk trigger (future date or membership threshold) which has not yet been met.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.86pt">Per Member per Month (PMPM) shown reflects only Medicaid premiums and average Medicaid membership for the period&#59; includes impact of dual eligible demonstration members. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">F.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.18pt">Fully-insured commercial medical premiums also include stop-loss premiums associated with the commercial ASO product&#59; for purposes of the PMPM metric, the commercial ASO stop-loss premiums have been excluded.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">G.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.3pt">Specialty per member per month is computed based on reported specialty premiums and average fully-insured specialty membership for the period.  </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">H.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.38pt">The amounts primarily reflect services revenues under the TRICARE East Region contract that generally are contracted on a per-member basis. </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.46pt">Computed based on average membership for the period (i.e. monthly ending membership during the period divided by the number of months in the period).</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">J.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.73pt">De novo </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">refers to all new centers opened or acquired since 2020 under a Welsh, Carson, Anderson &#38; Stowe (WCAS) joint venture</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.  Wholly-owned </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">refers to all centers outside a WCAS joint venture. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">K.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.52pt">Represents Medicare Advantage (MA) risk, MA path to risk, MA value-based, Direct Contracting Entity, and Accountable Care Organization patients. </font><font style="background-color:#ffffff;color:#ee2724;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.61pt">Reflects patient admissions under the Patient Driven Groupings Model (PDGM) payment model.</font></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.83pt">Reflects all patient admissions regardless of reimbursement model. Same store is defined as care centers that have been owned and operated at least the last twelve months and startups that are an expansion of a same store care center, net of the impact of the consolidation of care centers that occurred during the last twelve months. </font></div><div style="padding-left:9pt"><font><br></font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S-16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>a3q2025humanaincpostedrema.htm
<DESCRIPTION>EX-99.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0859de08f1ad4e35a0669180082cb065_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:238px"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please view these remarks in conjunction with our 3Q 2025 earnings release that can be found on our website at </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.humana.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> under the Investors section, or via the following link&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12.5pt;font-weight:400;line-height:120%;text-decoration:underline">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We also invite you to listen to our live question and answer webcast with our President and Chief Executive Officer, Jim Rechtin, Chief Financial Officer, Celeste Mellet, President of Insurance, George Renaudin, and President of Enterprise Growth, David Dintenfass, which will begin today at 8&#58;00 a.m. Eastern Time and will be available at via the following link&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations&#47;upcoming-events</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For those unable to listen to the live event, the archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page via the following link&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;events-and-presentations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain of the matters discussed in these prepared remarks are forward-looking and are subject to a number of risks, uncertainties and assumptions.  Actual results could differ materially.</font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other filings with the Securities and Exchange Commission, and our 3Q 2025 earnings release as they relate to forward-looking statements along with other risks discussed in our SEC filings. We undertake no obligation to publicly address or update any forward-looking statements in future filings or communications regarding our business or results. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Today&#8217;s release, our historical financial news releases and our filings with the SEC are all also available on our Investor Relations site.  </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These remarks include financial measures that are not in accordance with generally accepted accounting principles, or GAAP. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Management's explanation for the use of these non-GAAP measures and reconciliations of GAAP to non-GAAP financial measures are included in today&#8217;s release which can be found via the following link&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;humana.gcs-web.com&#47;financial-information&#47;quarterly-results</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Finally, any references to earnings per share or EPS made within these remarks refer to diluted earnings per common share. </font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify;text-indent:21.6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><div id="i0859de08f1ad4e35a0669180082cb065_4"></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="margin-bottom:3pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:20.00pt">Key Messages&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">delivered solid results in the third quarter (3Q25)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with Adjusted EPS of $3.24, in line with our expectations</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.4pt">Fundamentals in the quarter</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including revenue and medical cost trends, are </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">in line with expectations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:11.4pt">Favorability in the quarter</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including modestly higher than anticipated favorable prior period claims development, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">enabled higher than previously expected investments that accelerate our transformation and position us well for the future</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Our 3Q25 Insurance segment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> benefit ratio of 91.1% is in line with our guidance </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of &#8216;just above 91%&#8217; and</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> is inclusive of the investments mentioned above </font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">We are reaffirming our full year (FY) 2025 Adjusted EPS outlook </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> &#8216;approximately $17.00&#8217; and Insurance segment benefit ratio guidance of 90.1% to 90.5%, supported by solid execution and results</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> through September 30, 2025 (YTD) </font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">We now anticipate a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FY 2025 decline of &#8216;approximately 425,000&#8217; Individual Medicare Advantage (MA) members, improved from our previous expectation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of a loss of &#8216;up to 500,000&#8217;,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> driven by stronger retention and better than expected sales  </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">FY </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2025 Adjusted EPS guidance now contemplates an additional approximately $150 million of incremental investments, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">inclusive of the higher 3Q25 investments mentioned above</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:90pt;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.97pt">Additional investments focused in areas that have shown strong returns YTD and position the company for long term success, including member and patient outcomes and network management</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.97pt">The $150 million of incremental investments is additive to the incremental $100 million discussed last quarter and the &#8220;few hundred million dollars&#8221; within our initial 2025 guidance</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We are </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">committed to achieving individual MA pretax margin of &#8216;at least 3%&#8217; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">over time </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">We </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">remain confident in the overall assumptions utilized in our 2026 MA pricing</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">continue to anticipate doubling individual MA pretax margin in 2026</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (normalizing for Stars)</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">view membership growth as positive </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">supported by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">our 2026 MA pricing</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and the plan and benefit repositioning we drove in the prior two years</font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">We </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">expect improved retention to be an important driver of net membership growth in 2026</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, driven by our stable benefit strategy and changes to our customer service approach.  In addition, we </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">expect most of our new sales to be on contracts with 4+ Stars</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">Specific to new sales, we are </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">confident that we have levers available to moderate new sales volume for 2026</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">if we believe it is reaching the point that impacts our operational capacity to deliver an exceptional experience</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that fuels member retention, inclusive of our new Stars onboarding initiatives</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Efforts to strengthen our Stars program are progressing as anticipated</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with initiatives expected to drive improvement across key measures as we </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">focus on achieving Top Quartile Stars results in Bonus Year (BY) 2028</font></div><div style="margin-bottom:6pt;padding-left:18pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Medicaid continues to execute in line with expectations YTD</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">CenterWell is driving strong results YTD</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and we </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">continue to strategically expand our footprint, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including</font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">Growth of 56,600 patients, or nearly 15%, in CenterWell Primary Care as compared to December 31, 2024</font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.4pt">CenterWell Pharmacy continues to drive strong growth across payor agnostic offerings with increased Specialty volumes and strong Direct to Consumer growth, both exceeding previous expectations in 3Q25</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In summary, we are </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">pleased with our solid performance YTD and remain confident in our FY 2025 outlook, which includes additional incremental investments to position the company for long-term success.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  Looking ahead, we are confident in our 2026 MA pricing and benefit design and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">remain focused on delivering a more stable and </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">compelling MA margin</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">driving clinical excellence for our members and patients through levers that are within our control  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Detailed Discussion&#58;</font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Individual MA </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">YTD membership has declined approximately 424,500&#59; we now anticipate a FY 2025 decline of &#8216;approximately 425,000&#8217; members compared to our prior expectations of a decline of &#8216;up to 500,000&#8217;</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Improved membership expectations are driven by stronger retention and better than expected sales</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">FY 2025 membership decline largely driven by our decision to exit certain unprofitable plans and counties, which impacted approximately 560,000 members</font></div><div style="margin-bottom:7.2pt;padding-left:126pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:12.74pt">The plan and county exits have been partially offset by net sales activity (gross sales, less voluntary terminations and mortality), including the recapture of approximately 43% of the members impacted by plan exits into other Humana MA plans</font></div><div style="margin-bottom:7.2pt;padding-left:126pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:12.74pt">Further, we are pleased with a significant year over year increase in the portion of our new sales post the Annual Election Period (AEP) in 2025 YTD that are &#8220;bounce back sales&#8221; or members that left Humana during AEP or the Open Enrollment Period (OEP) and came back as of October&#160; </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">3Q25 and YTD individual MA revenue is in line with expectations and we continue to anticipate Insurance segment revenue of &#8216;at least $123 billion&#8217;</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">for FY 2025 </font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Further, we continue to expect our individual MA premium yield to be in the &#8216;high single digits&#8217; for the full year, driven in large part by an increased direct subsidy due to the Inflation Reduction Act (IRA)</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Medical and Rx cost trends continue to track in line with expectations YTD</font></div><div style="margin-bottom:7.2pt;padding-left:72pt;padding-right:-4.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Group MA</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">YTD membership growth of approximately 24,100 is in line with our expectations </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Group MA is performing as anticipated to date, with revenue and medical cost trends developing generally in line with our expectations</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We remain focused on improving Group MA margins through re-contracting cycles to appropriately reflect the reimbursement levels and cost trends, with the opportunity to significantly improve performance in 2026 and beyond</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We have retained over 91% of our current membership for 2026 through renewals to date, while re-contracting to improve margin</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">In addition, we expect solid growth in 2026 with the addition of new public and private sector clients including a large airline, the Teacher Retirement System (TRS) of Kentucky and the Alabama Public Education Employees' Health Insurance Plan (PEEHIP) </font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Stand-Alone Part D (PDP)</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">YTD membership growth of approximately 158,000 is in line with expectations&#59; we continue to anticipate FY 2025 membership growth of approximately 200,000</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">PDP membership mix, Rx trends, and member behavior are in line with our expectations YTD</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Looking ahead to 2026, we anticipate PDP membership growth to be largely concentrated in our Basic and Value PDP plans</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We anticipate low income auto assigned members will comprise a significant portion of 2026 membership growth</font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Medicaid</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">YTD membership has grown approximately 161,000, or 12%, largely driven by additional membership allocation in Kentucky and the launch of the Virigina contract in July</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We now anticipate FY 2025 membership growth of approximately 160,000, or 12%, down from our previous expectation of growth of 175,000 to 250,000 members</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">The reduction in FY 2025 membership guidance is largely aligned with national Medicaid enrollment trends, driven by changes to enrollment practices across states </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Medical cost trends remain in line with our expectations YTD</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We continue to anticipate modest improvement in our Medicaid margin in 2025 as states progress through the J curve and rates are updated to reflect the acuity level of members and trend experience related to the Public Health Emergency unwind</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We are actively preparing for the January 1, 2026 launch of the initial phase-in of the Michigan HIDE SNP and the statewide Illinois FIDE SNP programs, as well as the carve in of dual eligibles into the South Carolina Medicaid program </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Finally, we continue to navigate procurement challenges related to our recent awards in Texas and Georgia. We remain bullish on these awards and our ability to win new business and successfully deliver value for our members and state partners</font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:7.2pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:174%">CenterWell</font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:174%;text-decoration:underline">Primary Care</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Serving 447,100 patients as of September 30, 2025, a YTD increase of 56,600 patients, or nearly 15%.&#160;&#160; YTD patient growth includes&#58;</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">26,800 patients, or 34% growth, in our de novo centers</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">19,900 patients, or 8% growth, in our more mature wholly-owned centers&#59; and</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">9,900 patients, or 15%, growth in our Independent Physician Associations business</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">CenterWell&#8217;s Net Promoter Score has increased 250 basis points year over year, reflecting sustained improvements in patient experience and satisfaction  </font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We are continuously improving patient facing interactions, including enhancements in handling of patient calls and referrals and AI-enabled feedback synthesis to identify key drivers of patient friction</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We anticipate FY 2025 net patient growth at the higher end of our previously announced range of 50,000 to 70,000, reflecting greater than 15% growth at the midpoint</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Patient growth expected to be driven organically, by smaller-scale M&#38;A, and through the continued expansion of our ACO Reach program (Original Medicare patients)</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Current membership guidance excludes the expected membership impact of the previously announced The Villages Health acquisition which is expected to close in the fourth quarter</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Operating 342 centers as of September 30, 2025, representing growth of 41 centers, or nearly 14%, year over year, and reflecting a reduction of 2 centers from December 31, 2024</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Reduction in total centers YTD is driven by ongoing center footprint optimization in connection with acquisition activity during 2024</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">The impact of v28 and our related mitigation efforts are tracking in line with expectations to date and we still anticipate we will mitigate the ultimate impact of the v28 risk model changes over the three-year phase in</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Continue to anticipate largely flat margins year over year with the impact of the ongoing phase in of v28 and the addition of centers at various stages of maturation expected to be offset by&#58;</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">advancement of our ongoing v28 mitigation activities, and </font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">further maturation of our existing centers progressing through the J curve</font></div><div style="margin-bottom:7.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:174%;text-decoration:underline">Home </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Within CenterWell Home Health, 3Q25 and YTD same store admissions grew approximately 3% year over year, consistent with our updated expectation of a &#8216;low single digit&#8217; percentage increase in same store admissions for FY 2025 </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">OneHome has expanded the percentage of members in some form of value-based home health model by nearly 17% YTD, surpassing our previously stated expectation of 15% expansion for FY 2025</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">YTD results and FY 2025 expectations for our Home business continue to remain largely on track with initial expectations </font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We are executing on our comprehensive initiative to drive productivity and efficiency within our home operating model to offset reimbursement and other pressures&#160; </font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">These efforts include reducing costs by flexing labor capacity as admission volumes change </font></div><div style="margin-bottom:7.2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Pharmacy</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">CenterWell Pharmacy continued to drive solid results in 3Q25 and YTD</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We continue to experience strong growth across our payor agnostic offerings with increased Specialty volumes and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">strong Direct to Consumer growth, both exceeding</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> previous expectations in 3Q25</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income </font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Net investment income was consistent with expectations in 3Q25</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">For FY 2025, we continue to anticipate net investment income to be down approximately $100 million year over year  </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Capital Deployment &#38; Balance Sheet</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We remain prudent in our near-term capital deployment approach, taking a balanced approach to evaluating capital investments and returns</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">As a result, our 2025 outlook continues to contemplate minimal share repurchase activity to offset dilution from stock-based compensation, which was completed in the second quarter </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We raised $1.5 billion in the debt markets during the first quarter of 2025, which covers our maturities through the end of 2026.&#160; Further, during 2Q25 we opportunistically upsized our revolving credit facilities from two facilities totaling $4.75 billion to a new all 5-year $5.0 billion facility</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">As of September 30, 2025, we have no amount drawn on the 5-year revolver and no outstanding commercial paper</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Debt to capitalization as of September 30, 2025 is 40.3%, down from 40.7% as of June 30, 2025 driven by the impact of 3Q25 earnings&#160;</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We continue to target a debt to capitalization ratio of approximately 40% over the long term</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We continue to execute on our efforts to increase the efficiency of our balance sheet and fortify our foundation, including working capital improvements, non-core asset sales, liability and capital management and prudent debt to capital management</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We completed the sale of Enclara Pharmacia in 3Q25, are continuing to pursue the sale of additional non-core assets, while also making progress on capital optimization</font></div><div style="margin-bottom:7.2pt;padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Additional 2025 Earnings Guidance Commentary </font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">The fourth quarter Insurance segment benefit ratio is expected to be approximately 93.5%</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">with the FY 2025 Insurance segment benefit ratio expected to be at the top end of our guidance range of 90.1% to 90.5%, including an approximately 40 basis point impact of incremental investments</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We expect the Consolidated benefit ratio to be in line with Insurance segment benefit ratio for the fourth quarter </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Guidance continues to reflect the implementation of the Doc Fix in 2025 </font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">If it is not implemented for 2025, we may invest all or a portion of the one-time savings into items that position the company for long-term success</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">As a reminder, the One Big Beautiful Bill Act signed into law on July 4, 2025 included the Doc Fix for 2026</font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.16pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Humana Inc. Third Quarter 2025 Prepared Management Remarks</font><font style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11&#47;05&#47;2025</font></div></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">2026 Earnings Considerations</font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">While it remains too early to provide 2026 guidance, the following key year over year expected headwinds and tailwinds provide a high-level framework for consideration&#58;</font></div><div style="padding-right:-4.3pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;padding-left:13.98pt">Headwinds</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Star Rating declines for Bonus Year (BY) 2026</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Wingdings',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:12.74pt">Our current Group MA membership will remain on contract H5216 for 2026</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Pending acquisition of The Villages Health</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Net Investment Income</font></div><div style="margin-bottom:6pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%;padding-left:13.98pt">Actions Humana is taking which are expected to partially offset the headwinds</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">We anticipate doubling Individual MA pre-tax margin (normalizing for Stars) through pricing, clinical excellence and operating leverage</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">MA contract diversification efforts, which are expected to increase the percentage of members in contracts with ratings of 4 Stars or greater from the current estimate of approximately 25% for BY 26 (which is based on the current contract and member mix)</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Group MA re-contracting to reflect the current reimbursement levels and cost trends</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Medicaid pre-tax margin improvement as new states continue to mature through the J curve</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">CenterWell Primary Care pre-tax margin improvement driven by J curve maturation and v28 mitigation</font></div><div style="margin-bottom:7.2pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:11.1pt">Tactical cost cutting and transformation efforts, which underpin all pre-tax margin improvement efforts noted above</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:-4.3pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Consistent with historical practice, we will provide detailed 2026 guidance on our fourth quarter 2025 earnings call in early 2026.</font></div><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-style:italic;font-weight:700;line-height:120%">Conclusion&#58;</font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">We are pleased with our solid performance YTD and remain confident in our FY 2025 outlook, which now includes additional incremental investments to position the company for long-term success  </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:13.98pt">Looking ahead, we are confident in our 2026 MA pricing and benefit design and remain focused on delivering a more stable and compelling MA margin by delivering clinical excellence for our members and patients through levers that are within our control  </font></div><div style="margin-bottom:7.2pt;padding-left:54pt;padding-right:-4.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-13.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:7.2pt;padding-right:-13.5pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Jim Rechtin, President and Chief Executive Officer</font></div><div style="margin-bottom:7.2pt;padding-right:-43.2pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Celeste Mellet, Chief Financial Officer</font></div><div style="height:55.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hum-20251105.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:ac9ca574-edd9-47df-8fc9-1a02d1ef991b,g:b03f18ca-7daf-4a17-886f-cfdf6bfe8b15-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20251105" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20251105">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20251105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20251105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.humana.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hum-20251105_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:ac9ca574-edd9-47df-8fc9-1a02d1ef991b,g:b03f18ca-7daf-4a17-886f-cfdf6bfe8b15-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_bf57fbea-1464-4351-9cc3-660c81ef5b5e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_17472a97-f0f3-40e4-aae0-d41355616044_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a763449c-2399-4428-8b4c-abc6bc5429cc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_67944f3b-5a4e-43ab-aca7-8c7c04c5d820_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_aef626a3-3149-4701-aafd-5172f5c4459f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_2521f89f-ffe3-40d9-96f0-795eaf453074_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5e747b8a-3710-46bb-9391-fef4c26ea3b0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ccb79c06-65fd-4ede-9bfb-f76ac5a3d567_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d6f2e45b-a786-4c3e-85c6-60153cb66307_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0358d40e-cdb5-4d7a-9d97-44b7cf39b4db_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_64d55633-e4c0-4e1f-903d-10a753dd22c0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_61f3105d-9df6-4ebe-9cdf-c0d60a597164_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5987f6b0-f82f-4882-b544-216e78b6242a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e769a03e-901a-4152-9820-b06e972a7d19_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_382885c2-6450-4f97-ac72-a33a3a8ca0d6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1594625d-c7ba-437d-a22e-7c43219af317_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bd78d4a8-c43f-44ef-8b84-2fba5e98d0d6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7a278c37-9336-4c6b-bbbb-40748e2e0d29_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_16bef9f9-f32d-41ba-bb8d-8e679e5cbed9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0d968361-1c47-4920-a5a1-c7af180b750f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_38a3a274-fc54-47b6-813b-de8d5a164176_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ef68137e-b8cf-4161-bd7b-e166e4d34a87_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_56292d3c-32f7-4858-9a10-3e297c262c55_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hum-20251105_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:ac9ca574-edd9-47df-8fc9-1a02d1ef991b,g:b03f18ca-7daf-4a17-886f-cfdf6bfe8b15-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/CoverPage" xlink:type="simple" xlink:href="hum-20251105.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_82fc1dc2-9cd8-40ee-b816-81ff64f40d58" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_DocumentType_82fc1dc2-9cd8-40ee-b816-81ff64f40d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_cae7bc00-dc55-4e37-b044-9b7f02d978d4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_DocumentPeriodEndDate_cae7bc00-dc55-4e37-b044-9b7f02d978d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fb5f390e-789d-4de2-a365-c3c31cf93fdb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityRegistrantName_fb5f390e-789d-4de2-a365-c3c31cf93fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_96040196-0582-4fb7-beee-ae23de0449a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityCentralIndexKey_96040196-0582-4fb7-beee-ae23de0449a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9ee3d447-e9c9-4883-812b-7244f6e21f14" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_AmendmentFlag_9ee3d447-e9c9-4883-812b-7244f6e21f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4348c453-ba84-41e6-94fd-7134c6b27151" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4348c453-ba84-41e6-94fd-7134c6b27151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1074c1c3-eb1d-4f8d-acad-780d87b2cdc2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityFileNumber_1074c1c3-eb1d-4f8d-acad-780d87b2cdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_dbfeedbb-8f0b-4e50-ab43-8b5a4b101c53" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityTaxIdentificationNumber_dbfeedbb-8f0b-4e50-ab43-8b5a4b101c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9820330e-8764-404f-ac70-d8c7d82f20d4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityAddressAddressLine1_9820330e-8764-404f-ac70-d8c7d82f20d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e352b0b4-3ad5-4b45-a23d-9b4473dda950" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityAddressCityOrTown_e352b0b4-3ad5-4b45-a23d-9b4473dda950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_65223d53-3c32-40ab-8859-dcda3f07f627" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityAddressStateOrProvince_65223d53-3c32-40ab-8859-dcda3f07f627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bab93e38-d80a-47f8-8037-00fe3d85fe30" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityAddressPostalZipCode_bab93e38-d80a-47f8-8037-00fe3d85fe30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_69dda22b-d710-410d-83a4-d8cffdf3dc20" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_CityAreaCode_69dda22b-d710-410d-83a4-d8cffdf3dc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_81384249-a993-46d6-9907-fa006cf4800a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_LocalPhoneNumber_81384249-a993-46d6-9907-fa006cf4800a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_f4dcb43f-9873-4e8b-8358-7596e9c45ebf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_WrittenCommunications_f4dcb43f-9873-4e8b-8358-7596e9c45ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_55059d63-f05a-436b-b76f-4bd4e334f6c6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_SolicitingMaterial_55059d63-f05a-436b-b76f-4bd4e334f6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_978ecfc5-0337-483d-a7bd-50166110dab6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_PreCommencementTenderOffer_978ecfc5-0337-483d-a7bd-50166110dab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_21d7a250-9b33-483f-8deb-160ade629d46" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_21d7a250-9b33-483f-8deb-160ade629d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e58f2cf8-fb43-4a22-ace6-9ea98fe2a4a7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_Security12bTitle_e58f2cf8-fb43-4a22-ace6-9ea98fe2a4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ff0db161-39de-48b8-8832-2a7face2bd89" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_TradingSymbol_ff0db161-39de-48b8-8832-2a7face2bd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a0339d97-bbac-4a8e-a886-b06f08d22629" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_SecurityExchangeName_a0339d97-bbac-4a8e-a886-b06f08d22629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3a01ed28-72c3-478c-ad32-74b1660c08e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0f1f122c-3452-41df-b2fb-62dbc6ffd51f" xlink:to="loc_dei_EntityEmergingGrowthCompany_3a01ed28-72c3-478c-ad32-74b1660c08e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>humanalogoa05.jpg
<TEXT>
begin 644 humanalogoa05.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "D B$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS3$XZI.->5TB<OQ-2O)\[NCJJ***^\/;"BDI: "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH ^8_VW/\ D$^%_P#KXF_]!6ODVOK+]MS_ )!/A?\
MZ^)O_05KY-K\5XE_Y&,_E^1\?F/^\,T?#_AS4?%.J)I^EVS7=VZEA&G/ Y)_
M 5U?_"B?'&/^0!<_D*Z;]E#_ )+)8 C/^C3_ /H-?= 48' _*O0R;(J.8X=U
MJDFG<Z,'@H5Z?/)V9^>/_"B?'/\ T+]Q^5'_  HGQS_T+]Q^5?HAM'I1M7TK
MW?\ 5+#?SL[?[+I]S\SO$G@G7?",B+J^FW%D'^ZTBD*?8'IFL2OTA^(_@VP\
M:^$-2TZ\@2020L8V8#*.!E2#V(.*_-YU"2,N3\I(_6OC<ZRE974BHRNF>1C,
M*L-)6=TP;I7Z3?#'_DGOA[_KRB_]!%?FRW2OTF^&/_)/?#W_ %Y1?^@BO>X0
M_BU/0[LJ^*1QG[4__)%]:_WX/_1R5\%KW^E?>G[4_P#R1?6O]^#_ -')7P6O
M?Z5R<6?[Y'T,<T_BH]*_9U_Y+%X?_P"NC?\ H#5^@?\ #7Y^_LZ?\EB\/X_Y
MZ-_Z U?H$/NU]'PG_NDO4]'*_P"$_44]J\S_ &CO^2+^)O\ KBG_ *,6O3#V
MKS/]H[_DB_B;_KBG_HQ:^HS#_=*O^%_D>G6_A2]&?G]7=? __DK7A?\ Z_%_
MD:X6NZ^!_P#R5KPO_P!?B_R-?AF"_P!ZI_XD?%4?XL3]$5_AKY8_;@_UG@[Z
M7G\X:^IU_AKY8_;@_P!9X.^EY_.&OU_B#_D6U/E^:/JL?_NTCY;KZ5_8H_Y&
M#Q-_U[0?^A/7S57TK^Q1_P C!XG_ .O:'_T)Z_,^'_\ D8T_ZZ'SN _WB)]<
MUGZXH;1[U3R#"X/XJ:T*H:U_R"+S_KB__H)K]KJ_PY>C/L9;,_,B^4+?7( P
M!(PQ^)J.V_X^(O\ >']*DO\ _C_NO^NK_P#H1J.V_P"/B+_>']*_GO\ Y?\
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MN7CMQ/\ A&RR']%-?GTO05S<61:Q<7T:,\T3]JF>E?LZL%^,7A[)Q^]8#/\
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M7XKQ!_R,:G]=#X_,/]XD?4'[$/\ Q^>+_P#=M/YS5]%_$*,R^!O$"(,LVGW
M ]_+:OG3]B'_ (^_&&?[MI_.:OJ6]MUN[6:&0;DD0HR^H(((K]$R*//E48KL
MSZ#!*^%2/R[]N]7_  _,EOX@TR5SA$NHF8^P8$FD\0:3+X?US4=,G!$MG</
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MY!%>E&I&;M%W.I23V):***V&%%%% !1110 4444 %%%% 'S'^VW_ ,@?PO\
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M_7 _X5YG$V'JU,:I0BVK'/F4)2K*RN=5^S/_ ,EFT/\ [:?^BVK[Z["OBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>humanalogoa051.jpg
<TEXT>
begin 644 humanalogoa051.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "D B$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \S^,WQCA^$-KID\NG27XO7>,*CA=I4 ]^O7]*\K_P"&
MU[/C/AR<_P#;9:D_;:_Y!'A?_KXF_P#05KY-K\QSK.L7A,9*E2E9(^;QF,K4
M:SA%Z'W'\)OVDK#XH>)CHHTR;3[AHFEC9F#!MO)''0XYKVC/YU\+?LG_ /)9
M+#O_ *-/_P"@U]U5]1D.-JX["^TK.[N>I@JTJ]+GF[L=1117TQZ!#-((8GD;
MA4&3] *^:KK]M/3X;J:.+P]<2Q*Q57:55) . <=LU]'ZE_R#KGWC;^1K\OYO
M^/B0?[1_F:^(XCS+$9?[/V$K7N>-F&(J4%'D>Y]6?\-L60Q_Q3=QG_KNM?17
MAO6E\0Z#8:FL9A%W"DPC)!*[@#@X^M?F.W2OTD^&1_XM_P"'_7[%%_Z"*RX=
MS3$XZI.->5TB<OQ-2O)\[NCJJ***^\/;"BDI: "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH ^8_VW/\ D$^%_P#KXF_]!6ODVOK+]MS_ )!/A?\
MZ^)O_05KY-K\5XE_Y&,_E^1\?F/^\,T?#_AS4?%.J)I^EVS7=VZEA&G/ Y)_
M 5U?_"B?'&/^0!<_D*Z;]E#_ )+)8 C/^C3_ /H-?= 48' _*O0R;(J.8X=U
MJDFG<Z,'@H5Z?/)V9^>/_"B?'/\ T+]Q^5'_  HGQS_T+]Q^5?HAM'I1M7TK
MW?\ 5+#?SL[?[+I]S\SO$G@G7?",B+J^FW%D'^ZTBD*?8'IFL2OTA^(_@VP\
M:^$-2TZ\@2020L8V8#*.!E2#V(.*_-YU"2,N3\I(_6OC<ZRE974BHRNF>1C,
M*L-)6=TP;I7Z3?#'_DGOA[_KRB_]!%?FRW2OTF^&/_)/?#W_ %Y1?^@BO>X0
M_BU/0[LJ^*1QG[4__)%]:_WX/_1R5\%KW^E?>G[4_P#R1?6O]^#_ -')7P6O
M?Z5R<6?[Y'T,<T_BH]*_9U_Y+%X?_P"NC?\ H#5^@?\ #7Y^_LZ?\EB\/X_Y
MZ-_Z U?H$/NU]'PG_NDO4]'*_P"$_44]J\S_ &CO^2+^)O\ KBG_ *,6O3#V
MKS/]H[_DB_B;_KBG_HQ:^HS#_=*O^%_D>G6_A2]&?G]7=? __DK7A?\ Z_%_
MD:X6NZ^!_P#R5KPO_P!?B_R-?AF"_P!ZI_XD?%4?XL3]$5_AKY8_;@_UG@[Z
M7G\X:^IU_AKY8_;@_P!9X.^EY_.&OU_B#_D6U/E^:/JL?_NTCY;KZ5_8H_Y&
M#Q-_U[0?^A/7S57TK^Q1_P C!XG_ .O:'_T)Z_,^'_\ D8T_ZZ'SN _WB)]<
MUGZXH;1[U3R#"X/XJ:T*H:U_R"+S_KB__H)K]KJ_PY>C/L9;,_,B^4+?7( P
M!(PQ^)J.V_X^(O\ >']*DO\ _C_NO^NK_P#H1J.V_P"/B+_>']*_GO\ Y?\
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MN7CMQ/\ A&RR']%-?GTO05S<61:Q<7T:,\T3]JF>E?LZL%^,7A[)Q^]8#/\
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M7XKQ!_R,:G]=#X_,/]XD?4'[$/\ Q^>+_P#=M/YS5]%_$*,R^!O$"(,LVGW
M ]_+:OG3]B'_ (^_&&?[MI_.:OJ6]MUN[6:&0;DD0HR^H(((K]$R*//E48KL
MSZ#!*^%2/R[]N]7_  _,EOX@TR5SA$NHF8^P8$FD\0:3+X?US4=,G!$MG</
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MY!%>E&I&;M%W.I23V):***V&%%%% !1110 4444 %%%% 'S'^VW_ ,@?PO\
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M_7 _X5YG$V'JU,:I0BVK'/F4)2K*RN=5^S/_ ,EFT/\ [:?^BVK[Z["OBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" %U!-4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML#[E-7!#D4Z@# HIK5#"BBBF V0 CFF!0.E2,,C%-*%14M1OJ)J^IQ7QY/\
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M>/0TKJ]ABT44A< XHN@%HI-XI00>AI@%%)NP<&@L!WH"XM%-#^HI2P'>DFF
MM%-9^.,T!L#DTP'44A<=J9YV/>DW8:5R2BF[SZ4X'(S36JN*^M@HHHH ***0
MD 9-#=D M%)O6@.#2335P%HI-ZTH(/2DIQ86"BBDW*>]5<!:*,@]#12YD 44
MA.!D4F\^@I[@.HINY_[OZ4I8 XH%="T4TN.PI00>E2Y)#%HI"P7K06P,BG=7
M 6BF[SZ"@.<]*8FTAU%(S;3C%"ODXQ0',KV%HI"X% <&CI<+J]A:*,CUHR#T
M-)23&%%%(S@<4P%HIOF'T%.H ***,@=32<D@"BDW+ZT;ESC-.X"T4A< XHW
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MJ>K/R_-_]ZEZB4J]1]:2E7J/K7R<CS:>S'0_\?*?]=!_.OU\_8#_ .2$6/\
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M^,^];2;2YKE:VN/('8TH( Y;-1">$C(E7\Z#-'CB0?G252.S:%>ZO<>3DT$
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M4WHBK*PE'2@\\XI'SCBK2;=Q)*3%SGO2-N XI8B,X].M(S@\C!IR:V&[1=[
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ML<&GT@ W9!I:I;!>X4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?>GQ?ZK\*_F26[1^;R]UJPUA@@COUK7\!*&\6VF>TZX_,5D.0,9]:V/ ./\
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M'05)MS^%)*0BAS^(J.;W_0Q;;1TOPG^)&M?#3Q);Z_H]\\(24%]AZ@&OU?\
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M#::M VQH9@PQ[5^PG[&OCU_''P=TB_EFWN+1=Q)SW-?C2SJ6* X)'!K],/\
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MM3?^6E2/U_"OPQ12U/BV]!M?3_\ P2G_ .2ZW_\ UXI_Z$:^8*^G_P#@E/\
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M +![?S%?C!XF_P"1AO?^OAJ_"O%/_>:?H?'\2_&O0HT445^-=SXN.["ON/\
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M7\*C_P"6E22<M^%?AWV3XKHAM?3_ /P2G_Y+K?\ _7BG_H1KY@KZ?_X)3_\
M)=;_ /Z\4_\ 0C7U/"/_ "/*7J>MDW^]P/U.@_U0J9/NBH8/]4*F3[HK^KZ/
M\-'Z6OA&2_<;ZU^:_P#P5J_Y'RW_ .NB_P#H)K]*)?N-]:_-?_@K5_R/EO\
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M(_"C]"MJ%%%%4,*CNO\ 4M_NFI*CNO\ 4M_NFLJW\)B>Q^2G_!23_DXO6/\
MK\:OGQO]4/\ >KZ#_P""DG_)Q>L?]?C5\^-_JA_O5_)W%G_(WJ>K/S#,_P#>
MY>HVBBBOEX_&>4]T>@_LL?\ );](_P"NI_F*_9OP5_R+5C_U[1_^@BOQD_98
M_P"2WZ1_UU/\Q7[-^"O^1:L?^O:/_P!!%?O?AG_NTO4^YX9_AR-=>_UIE/7O
M]:97[#T1]:2+T'THH7H/I15""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *9<?ZIOH:?3+C_5-]#6=7^&Q/8_*/_@I[_P E
MUO/^OIJ^:V[?2OI3_@I[_P EUO/^OIJ^:V[?2OY0XN_Y&]3U9^7YO_O4O42@
MY[44 9.*^5TOJ>;32:=Q]N<7,?\ UT7^=?K]^P*/^+!V!!_C/\A7Y P8%RG_
M %T'\Z_7W]@1L_ :P'^T?Y"OUKPQM#,G);6/J^&;?67;L>X<&@L,?=I6&WH:
M=L6OZ!3;W/MM=!H4D9 HV-Z4\#' HJBM1FQO2C8WI3Z*!:D<H*Q].<U&4 ?<
M>]3LH88--\E!R,\<U+2CJ@N[GE_[5/A2'Q7\(M4L9HP0D+R#/^RI-?C1XDMT
MM=;N85[3,/U-?ME\>6(^&FK$?\^,O_H#5^*7C$ ^(KLG_GN__H1K\'\4:,%B
M(3[GQ7%";E'E,T# _&GG&>*8GS@@]C3Z_'9.\U;8^2^R%>]?\$\_^2WV'_7R
MM>"GH:]Z_P"">?\ R6^Q_P"OA:^EX8US:"/0RW_>XGZW:/\ \@N'_KFO\JM+
M]\?2JNC_ /(+A_ZYK_*K2C+9]!7]6X;2A'T/U&/PH2?_ %1K\YO^"P) \4:&
M3_<E_F:_1E_FC.17YS?\%@L?\)-HF/[DG\S7Q7B%_P B*2/%S[3!MGQ(W*$^
M]/B_U7X4Q@%^4=*<G"8%?S)4TD?F[5VAR]1]:U? '_(VVG_7PO\ ,5CL^P@*
M.];'@ J/%=ID'_CX7_T(5W98KXV'JC>C_&1^S7[-7_)*]-_ZXK_Z"M>B#I^-
M>=_LW$+\*=,(/_+%?_05KT%7P.?PK^MLF7^Q0]$?JM!<M&*\D/'3\::_7\*7
M.5R*:_)!]J]./4Z!R?=%+34)Z4ZJ>PGN><?M4_\ )!O$?_8/;^8K\8/$W_(P
MWO\ U\-7[/?M4_\ )"/$?_8.;_T(5^,/B8_\5%>C_IX:OPKQ2_WBGZ'QW$VD
MT4:***_&NY\8EJPK[C_X)'_\A"Y^LG\C7PY7W'_P2/\ ^0A<_63^1K[7@;_D
M:Q/<R1WQL3]#;7_5_@*?_'^%,M?]7^ I_P#'^%?U#3_AH_1H"2=J_+3_ (*W
M?\G+C_L$P?RK]2Y.U?EI_P %;O\ DY<?]@F#^5?GOB-_R)7ZGB\0_P#(O^9\
MKI]T4O:D3[HI:_FJ2O<_-ZFX5TWP@_Y*OH7_ &$(ZYFNF^$'_)5M#/\ U$(Z
M]3)M,=3]4=.&_BP]4?M/\*/^1%TW_KU'\S72IU_"N:^%(_XH333_ -.P_F:Z
M5!WK^N,NTP4/1'ZM0_@Q]!U(W;ZTM! /6NY[&Q%<]#]:^%/^"KW_ "#+?_KH
MW_H-?==P.*^$_P#@JY_R#+?_ *Z-_P"@U\3QS_R*)GCYSK@I'Y^+T'TI7^\:
M1>@^E*WWC7\O5?XC/S66LV(/O_\  :LZ'_R$8?\ >JL/O_\  :LZ)_R$H?\
M>KIP'^]Q]2Z'\0_83]BG_DCVG_\ 7!/_ $&O9!]TUXW^Q3_R1[3_ /K@G_H-
M>R#[IK^M,A_Y%E/T/U7 _P"Z1] _@_&A/O"C^#\:$^\*]CJCJ^P*.I^AKYG_
M ."G?_)M>M?]<?ZFOI@=3]#7S1_P4\ '[-FM#_IB/YU\]Q7_ ,B>IZ'GYBKX
M.?H?E"/N?\"I],'W/^!4^OY.Q?\ $9^6OXPH Q10?ND@\UG33<D$-9'ZB_\
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M#]X4OM".+^.QV_"[6R?^@;-_Z :_%/QB0?$UV1_STK]K/CUS\+]:'_4.F_\
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M4O42E7J/K24J]1]:^3D>;3V8Z'_CY3_KH/YU^OG[ ?\ R0>Q_P!]OY"OR$B
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M_K3(O^193]#]5P/^Z1] _@_&A/O"C^#\:$^\*]CJCJ^P*.I^AKYI_P""GO\
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MHDXK5BCL/ZT4T2*>,')[4K/M .T\TDXRV&+13?,]J<#D9JDK %%%%, HHHH
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M\HV7[C?6OS7_ ."M7_(^6_\ UT7_ -!-?I/+]QJ_-?\ X*UD#QY;DG_EHO\
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M &@/VO/ /PLT:9TUN"2Y52!"LGS9KR\PS+#8:A*4YI:=S&KB*-.+YI'Y]?\
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M!-?!>(&F4RU/'SSF>"9\<@X I:11\HI:_F1M-L_.9I\]V)@9S5[PS_R'K?\
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MJ4'#2,CS9JK.>A:TC7M4T&_2^TN\>-U.00V*]W^%7_!0#XJ^"$CM+S4'GBB
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MV2?A3W\.VWU\E:]6VC^^*0@#HU8+(,N<K^S0+!89?9/.M"_9I^&GA^\6^L=
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M'^&$"NV;<!UH3H:[Z.1Y=0^&"-E@\.E;E,K3_!VAV"@6^G1*/9!6C#86L/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "DVC.<TM%)M@(R[J%7 Y I:*2;
M,#T%-921\H%.HJ@$5<4%03FEHH **** "BBB@ HHHH ****  \C%(J!>]+10
M $ C!H P,444M "C'.?2BBC0!&7)S1MY! I:*8!1110 4444 -=23D4FQJ?1
M4N:0#0A'IFEVY'('X4M(Q('%*[EL FQ1W-(,9]J 23@DTX*!R!1R6W8-"D>E
M,P1D[N_K3Z0JI[4<@#23TS2ITQ04(Z<TJ @<BJ2L-M6%HHHIB"BBB@ HHHH
M#GMBDQG[P%+10 8'I1@>@HHH 0J#VH  Z4M%3<!&!/0TM%%";8!1115 %!&>
M]%% "; >I- 0 YI:*FX!1111< HHHJ@"BBB@ HP#U%%%)L P/048'H***5P#
M ]!1@=Q1133N 4  <CO113 ****FVH!1115 %%%% "%@#@TA 8?**5MF>:
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Humana Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-5975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 West Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hum-20251105.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="hum-20251105.htm">hum-20251105.htm</File>
    <File>hum-20251105.xsd</File>
    <File>hum-20251105_lab.xml</File>
    <File>hum-20251105_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hum-20251105.htm": {
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20251105",
   "dts": {
    "inline": {
     "local": [
      "hum-20251105.htm"
     ]
    },
    "schema": {
     "local": [
      "hum-20251105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20251105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20251105_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.humana.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20251105.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20251105.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000049071-25-000055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000049071-25-000055-xbrl.zip
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M(Q\V))J2.+ V&'NV_\_^\'DM"33R4(Y]9"!X5C1/P-!^NM_I#UKXK'A&D9P
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M*B-E2U+&Z@/J=7OC=)2&-O=$F[%I55?>+99$XDKJM-#PNC(7=0V8\$^,\?B
M14>-3ME5],J,PRB->:/U-ZYEBU5:C6KL":M3S'MQ/Y0T&0+K76!AJI4,^WLK
MW@@8IAI8'*52#GYV$-BE@@;NVC!B$5JY"Z-KP@BN%&X3T#V5SKOK'^]^.G0V
M7'4[;S<2Q$:8'C6S084Q*$JD*X&;D7C*3'4/R01!C&![1#G5*5W'1#J,34K=
MO(W?>[B'C-EB.DMB;H3E4D"50(4K+(:1TB*65F*1AD-VQ"$H3]PH790O;HM6
M'!N'$B5>RJ&E9?RK1:HZ$QB1JM2-LS3'.[BOWH*-E7.K')H974U;THU;"F%C
M3@5LNIE#N2,BH9@B"CJ$8B(4I4"N $<8O!PJ8BC-;2*1H/* FI$*B' VKD:U
MH1RYV61U84"-1K1OW<2\X82-B^) -;MHAL5PFC@DV;I*P]<C]%S!_H4O C["
MIEX<7ITX0!>*/!\-:R(26Q /S=T=0;AO6K";4,YVT.Z/UL\"D]T3<'4BOYW#
M.O"?5[5#P%9G'_NEV<?4S,XI,SMOV!G-#0WKI>'7U:;P%E.W=F0U68];C:VN
M9P[!;8=E/RK2/7FSV>SN-4NZBXD2][1U-RI NDL?\HVKFQ[TXC\0[G352VQP
MIPWN]$?$G6XI46JJEZ1W13#_6303.B52GYEF5_7(SF9&Q0XL022X+ ANNYO-
MN5Z)3=]D@S2TJZ7\O8C0KI3 ES+AT5H26PCF:E>NIUC-&IKA9<L)\QT-@]Z%
MW5:GE#WA,1[+W@ELFDY4(90K>\L# D5>3(6X'IY\GZO8;-2=S@V)D\PO]<[!
MC$T;AZIB>(]8PB]8@K8E]\!+3;EI+<I&AC_\_#?RWC$Q9(*^[BK%=G?5%&F6
M;#,]IIG.O$7 ]U@3SA0C82TB.YG6*DL#I2YSJ4V(-?P@PCB@EDLR ID<,#W%
MQ $8XEGB$2(IARP6T7U?@FM(63O$K>I4>9<V4XCY!1%I;H=-$!+:J'>XC; ]
M9JE=CH";^PX"O2-)WTB,ZR4&ETB_IW =-TO4D<H7(\*T70K8WQ:W2BAVF>@T
MIZ!I-#MT1/>4*8K*+-*&,$X5%(TMOL'F2[;U!,O'2#IT+ 9QYZ5Y0Q@,I+%5
M68RO[<";,Q50;9@'OJ,TI6&!N2$Q:#I7Y>\(YXN'/QUT#HNW13.&^N? #=C0
MP"N?#CO=_ ![B2TZ>39R;3NY=@U.?VZ'&D5 P1#'D3,_X6!IFIY)CI:&3>!$
M5%$1]F)*-<XA,%FP,!2)1QV_>+Q-249#XBU(_ XE#>HE8U@X3/UU%1J(SQ]T
M._N5-JWPQ>&>/>6W+!+%T064OPK"I501<$B$"08CB1KZUX5:J QU140)6*9&
M ZWR!65M5WOX#KI[!58^P)0,VKR-A5&SA5%- 2(N13A4BD,G8&FU Q.2B5!
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M<C3I]L'A 2=^'QWN"CC=AX<'[+0^/CRTSAVMRX)55Z9=/"QYOIC'290D6$2
M(&QV7SJE@ D: 1;'+&:)8&;:LV6J%?G(,&VU@HV8/41M]X?I\?;DAHVE'2=<
M.E/WXJ0=:3) .@TTR>A>X#O(?5R)O+C)B_J4QT7)2G6:WZ[*XN$TEVH.<8I(
M9+9#@G+3?&(J 8LB!:A <0139C9+CN_0#>I-,^:U4O@EJ),P50NVB015)JZS
MWW 9;4?!9RN.UV0XJBX>XZ*5VQ'3XW#\B8=)*[/[LZ7=P_Q'31CQRZQ<J#F7
M-)&()<"0;79P2&F0\,3LX#1G6*6)=&B)3X,?NRM6&D&N QC]@_\SV*F[SYB/
MQ;"?+WTL.C9)1W=>P^53&Z,&R\=@DP^53VUT#91[:WP[YSLIS=.VKJ'\7)P7
M^??,)#JG+**)B"E(X[AZBYUPP,T_@$**$A6I4$;6^[4AH6EZY5:[T0UV^JX=
MLJ=<MJUQ?!&\>J*'?X]..&QN1 OL"3QQ[QNVM]_T#JP?">QYOB[9XC_9S6;"
M)5SI5*= QY$$")HQE_-$@D01FBHLN))^N+9D)H9UHQT8<:]AMK-0CJ!ZVQ^'
MJ:US?T@[C8U'M!WVYP#:::T7S^[5(^$\-3<_%Y?YW6H>RI0D,8$ "D0!2J,0
M,,R@V8HR#9.04QQ:7S#4HS$QEI5PU4(J:4\F&_5Q!-+/]3@:K0S[H[AO:3R'
MC9@_!\)]4[T$=BP=B=_VQUFV4G >)RPVPRP"6F $$.4$)##F0*I$&A )@M1Z
M2]BK,C&"VQM!I1U\7OFVQE:='$'T=3\.16OC_CAV&1L/9"OJST&RRU@OE)V+
M_2^BO30/G2M-#'E4 9X(;894TQ2YI!PH2(A",D8LL3X-VPQ\9/@>KR2MM-RO
MDZVM'X;+UY ;3W9>O"Z%;28^Z@K8.M#D%[XVT^^ZWK7U=X\O6:C0*A2K-R&8
M1&DD8P'B2)N9,,$)2!D,0:RBE(J(1 )CZ^]8: 0^,@CU'%1I.6['6MX/D^#K
MR(T$2S-N7Z[0D;G?=RLT TWWU0H=Z;>^6:'K[WTH-"MJNLBWMR]V]V2;;^M\
M^^+_4$L#!!0    ( &<Q95O7LM OL 8  .4P   4    :'5M+3(P,C4Q,3 U
M7W!R92YX;6S5FEMOW+82Q]_]*?9L7TLO;Y)((W'ANLF!<=S&2%RTZ(O RW!7
MJ%8R*#FVO_T9R=[&CN-6L 2L^K(7+:49_N>W0\Y(;WZXW9:+SQ";HJ[>+MDA
M72Z@<K4OJO7;Y:^7[XE:_G!\</#F/X3\_N/'\\5/M;O>0M4N3B.8%OSBIF@W
MBW8#B]_J^&?QV2PN2M.&.FX).>Y/.ZVO[F*QWK0+3GFR&[;[-1X9IYU),DG
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M#]YR0Y[R;P+\;D2Q)EP)N,9B!1%%Z^*V73L=W!IITFU7:X>7)@VGV24-Y\7
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MTR3$Z=(*XQ&[%[Z/_S(EO!"^]R6M&CD9":QX!4%[GI3QH7(PW1;9NNY#=$L
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MPYY >3N#W6_ _$+X;!)&DF+F((X236A]J0S.[P6E1MK7BLBO;T027G1'4RR
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M<. KH!_X$]UCBZK0I$.3ID *3R,LUHY9A^BZ6F7<&3OL+0>V44 S<BR >?K
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MXQ%P/@Y\!!B06/, 2'K:$_F9&+)QV/N9F=P3OA1WM+2>8@J+S.(X]R-TJ;4
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M.J3A"F19^(8>6\38(6Q4D3$9KTF(F]G8^Y5I+_A+8SP)0\M(^W<IR11BJF)
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M]SV9*[=2*BGVUQI:\CX6VQIJ6T-M:ZAM#3T)Z.V\-?0I^FU/D;=J6B1S@';
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M3#FD.:0-3#(,X:,X0>V&:8AX%!J=EI.KK,?13DDF83 O5]$PN0-1S@9:7E8
MIUR.TRW!OX@_%,QI@H/H"<2P3T)8;QEL,[B9ONZ#1>"'$ZTO2%'RR*R))E(
MUTV9CQ?I3>JOB)8GL\?-.RL>,*$,$H*X$G<2K< YQ*8:R,"1Z==CP2&!%A>
M3>;BC - L"=*:1..\(2_P;D-\-$@ ERG$!WSK\C-L-DH0OW R3W2SS0<A-:?
M0J-HILE2S@78: [UIKG+[@$-(D_I=':@BMD) 7"A?X>L \9(A,;;'TF?NL4,
M^-'M R!%P'/*5(KAJG .,GH, ?>$Q\%<Q7-.F6;%&':&U!OANF06HNPP_AJ
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M,\3@A#V4F*L3<Z_A-@<$1^((<]V=0\[2"E:6_9A(?LL._!"\:NL14&O=>3X
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MH3:C,F)H [ZU9V*/SU'J_6"MUX'_U5F!] /E]9VF*_KH![((_-7N=X8R'O\
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M/*_(?2BVCO!)^';P)M;X,D 7Z%S'GP/!'^M!&%IG/8BD_\2G; W?A<5LT0;
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MYTGLG+\#]_#]M\/Q2R!\_HQY$'.>N%"^YF7'P$ZGRH2/,3UT"NS04":Z4?\
M5%T9C:H-0.WW8\?E7\LIL-7* W9%<SH&=ILES[4P.?NUOMFO<J3I?@ =5VIZ
M+0!* MMRWNN)\UYEPZM]HOV0(;!7.&+.'$S&<C9A&6S4X7$E\3V"30G=:*.!
MJ9T9.+TLYM2&@XDZ.DUF][W9BVRC?6 [0D.9UAN!E]UI97?:$_H1:HIQ%;0A
M&VD?+JMT92QEE915;6%6H,=#FZ?F(2-;$EYI9*'&EH3]]Q<-];A 7X\@4]9I
M:J)?.V3*8@SGC[_T,\0P4%6]S@B#;$E8VI*0/+./:TO8!(1;Q-N&.9%@.YRU
MA\9QP?IK 5NI)M$UHT' ]53-:*/)KII)VA+6LY83FIT=_=)K[7)XKI3/4]NR
M%*8-]:I9X:8 L+2@/BDRR0"CN'?>IN8PR?=.2THV+<J::.TA2F'3A6XG@)8U
MX4J37UDWA4R":Z[I1UE6>SZ%_5Z?$(#-%U;DX^):6(.I=F2JGX%/SEN-U:+*
MX28(.JTD"8O;BS8&'M$\A], <! 3%+NBI+C$(%N!MEU!74<1VG!:TF9-=ALX
MN?H)>R0Y(%SG*#1#"L!\0O!E&_9E)&Z1D#VA>$VB_'PH1\S%:_ &OB"J[WTW
M7J5M&+,*84W10HP>R4>A3K-]LK"F,>V45206>/<1?%<46$D3H(UF3FCDV-Z7
MFE&M]6*3"N>2?7GZQ3"-\ 7KF;.QJS=$S9KFI%7<A:*NJ"75RHKB('7+MBI^
M0;BN@"GN1&43%N8YV(ATO\R\IIX:XSP46ME3HR86O#9..U>U?(TMCLZ-DEM*
MB94VQ\MU]5O1*'#L3>5N1B>GI;X>0<H/R>V-9L!%(+[OEOB+F8@:[(,)$,:0
M'VL=Z-)L?>B<"S,G). (>0!G!+F+CDD!"*O5!$_T;M<$O_8]K&[%NE5XMUM2
M7M;8](XGJ4H=_R4I; 9C#BMND:LLXB*'_1G3$#=\PUJ@>B%6Q8(3RNQY5GP.
M=/<88F>YB$R8%:*JQ%)6"GEKA4!\0"P@U4GD8Z>IR&<QQABT'C:CV\02.==N
M"%?XCVF[.<'":=TU%@+;D3@KXQ%-T)@TI4F%O ?5B&T"[+2_UYZ=#$AV^VO<
M_CJ@8'1AA3!\?D=%V N(\DN81%W_D3JYHK PC;EBWP+X]3WKUPFK^\3T+*X5
M>8\\6T;1FL^+8.7&[(\E6X%R9X> J)D".V8?IS "+0 ;7;'GL&]2'_M&0.]Y
M;37*%R,]UISH%=BX,QNH)<$4Z]29BA<;B\"QO'L&<L^V,00W)_>.1;9J\<N@
M#81Y +R5K?RL3D'R_8(\^G&F=1\8EU]0%UHI]9-Y'&PZSNWAB#43ZD#S=P[R
M,8K]A*$ HDP#P *^D)M"Z":W@6/@+905G3L6;NJ>!BFDDTO8+S^_!V=B/!M.
M)^/Q;#JT1[IE&I/%?*%.AB/X=&KO$G?;Y2I#R3_7 '.^5:XY!B0"?;E>8C-I
MYM8AIK"C+Y,] ;4IBET+6U O','O! 2/XY(YC> OQ-[2?T I]!\_#:>D*@C9
M10PZ2%LWS+G\(%Z<=@JV2.PY0 #IV@ D[]_L:S?3OKE4U>.W0G^ /7,'M@].
M6\E"WD4Z1&'#Q H"#"0"$:IH"[2$]4S%6%? P,KX(L+6$R"_P(@"\Q2\HS#+
M+HD+!W<KY!U[K ^<%7O,600TIHN)TL;X3/?BX47$>W3>.T&$/7! +878#)K[
M?H&]Q.L8Y:!TO ?RX/TF^5-^<5 @,DON#RYB>0?8CYFGY+06:T14BQP%;W2]
M#OROX/%&V(DY>O"!:N,@S(Q-2C<JY'\A]56T(<T]-F1RDH[F>W?,RO0\MXIK
M,KY07Z/*G+:TPHW+L'MHG'@>?AP5>Q,8!.3]80 &C)ML -*<,10[P<-S!H7\
MMK'.9M1U@&-"?F?$@FB;,^J')?42[N%.###V?V*/D_ZFDZD?8+LCGW<W9F<9
MFV=@SQAGSH7S"IX%CPQ%5Z2T0Q*P,XL&P7(QA$/3=JY\]A,SE_]+"XU:&^_;
MQ([@!V;P,1%RCX?]8$@K!+R-D(+@]B+LBYZQ3N.0[1VWG1S7DV?)$7[1P3U&
MG@ ((9-^$5L>Z 1\)^NZ95LL_I@/0.47F\:P,IEKS.T6+8=1MK&?<CD":*]C
MW@&3N/C69/3.S<IBULHZ#L &%]WK 5.@]V@ @C6-B %AP8IY &"U!BRP;Q3R
MH=J^0R [%_M@\^W/66LB)K"Y5PWK'L#>(D9Z+#R'$[4B)P+)CJL?H/ 'UYBR
M]LIX<<%+4@>BE'9? 3@*;BSSKPF?!%;X,$"<R_" :1T/3D@3#-*Y0CXFEEPF
M8V21"!?108R;%CA"C/6?6R>0II:]9./M #@B&019-NDP5L38/L$@_SU3&-4(
ML17!EVHB[IGU7*CPM!D:$-%]0D&%B!L430LDO)]5(B#3MM$)P H@N]4:D/$4
M*%G0,ZCS07G^D4@QG.ZPSNKT,Q5!'9BS=$NC2$238%W)?"UW$\Q&M]Y+&/]7
MU@'0(Z'EYJ?'7+BBBRV=4S\;O=$.6 X: 0,3!X*F,B#)D"9H8?!-+#?T-\,W
MWOV;]YU-\\G>?KQ%X@4Y_  DZM4[LK3:3AH!'[.CC3,X66V=:54-+&<Y9'@R
M6W?WD,%05.82O (++BIM'8CP<Q:.\+,BR[MSX,>0W#1!4>3681&9[(KO+7;&
MSB=9^2(_!Y[)HZG."G40\+!E_QD[_%0O.47,&Y09@QJUVE<V403/#[@9C'81
M,W6?LB'9")*,,5MH(7+/&!WL1*URZ9#FC!0JU@NE3%3#1<Y;V,Q=$%X0 Q.F
M73-2 NLPLI(A:.!:@$3D+30WS5GQM]T#G/ '?&!!R0B?"\$;2'(A+-)Y^:%8
MOH-KGF"$VF6F()/PXEW[DPK*#GHKAX/2NR[;]7*B*U-M=$S72T-7S-&D_H:/
MIC*<Z/*QP\FHH:Z79Z@AJ[&MY).INBP=(:>TSM;B4C_<7.5-+UO1\K+Q9GO5
M4-E0O\ON0*>)9I<=@4Y+.UUV"WJ'M;FL6:T<#HYS6+2B.'EK4D 5JNH#.$I*
M.RO)G3[LOZPB^%KV7U;:6ZFN]X(5NFTBCBW@5).:EZD.;Q&8=CWZZB358V"5
M,%RE!@2]!TX9PU7J5]-[Z)0V@3H_=/HIR(T"09XT6C@H^>Z::DXF6T&--M2<
M-#S4KYN'/Q_CB"6PL60_+!@1QT"9T\["$<A;^3%XD+^)^..1"^"5C]EVD$)Q
MZJ?#,NWX,V\:.9#DI8;6RH_9O@*:#'P3Q6@+RPE$U8PXV'@2 MLEO2SOE=XY
M-DMS]/BT/IX+%6 2Y-;HT<U3RC*,]HW4[==Q\3$G8L<?0C&<O/UX6YZ-TS)Y
M4L34[9,G_RJM.6N4Y^VE%=RQHT%DOUWN\[T[GR4KI>MEU3L\L6M3?<9E0U*V
MPW0O<#]+W^259:Q"+[3NX5DL@7(>BZ/FG5FUV]5Y_)@8FP?X<9B5E8-,<Q:'
MY5>R\V=VIAUB<30FGCC!BB5/AVR\*,O>YCOF=P.1T@ W@#>+@L%P3>$;/"EU
M%B"N.$A8*MVF3)#DH<>*L['G48!97#SM% 77&O-Y*9MMZK+WL4Q"U_7MK*Q+
MCG2/._LNY71^0Y(U>-CQL\AXWUQ95*!_9@E<S-?E.3-M$4L'97ZW3U"]3YL7
MT:\._WNU=OU'&F"WI'B-PF%% Y&3.&=5!8*APXV>;H,=LY%I25[+)L$RV1O[
M^8C]8<ZEY\%[;#[.5!0.@KQZ1V=!C&:/;@SP$ 'SO([@ZZNQ;DZT5%J5^I,U
MFQH1BI=$W*M4_8/R1=6/)[)IHR<\/AMD380T#323X<Y0S-*+\GA.^K4-\A_/
MJ$<7CM ^@Z<5U*!@QO7FT;O?;3V_VH#L[7RMS"#EHO2LUJNO3BFKZJGDS2@D
M5CO'JR&2Q6VJ<N>;U66,;BSL".*T-LFCF=(D"TS).]1+5@1VJU LK$PZPW;F
M&6S"'7NPF.8+N[M=GEB^^6F?^CP;LJ4@:$X0E%:)-&:(8MYM$KHF3LA</PQ]
M[;9R J_1\5B@# MCV?(SA72).\;U)V^M>^?!6C+E0OQ5(!CF/GM/0!<NL'RN
ME)!W3]OD7U]">J2QI/9[;9T*3K]/(QM)"*(1>=>$9&^FO");TIQA0!;=M\)E
M)M2T%5&;9U4_4O "PTCT!NO=YYFZ$1ZRVJK6V(@(;-"!%?0L&,][W&PJ [-%
M%6@TB+=A R?L(1=\H=%9(U9GM#L.CT5UKR:JX_&BU_$JYD>YQ*- 1X!#T?^Z
M*=4+E+8YI@."$N7^PLK.+S??JCM?]H];25Q"/TC+8[9.JBS@/>:!@(9%6F=5
MO;L5O9L*W3R7*&5:F#4^A17DML+4>EC09-S-VC^;]KF\W2K6 5-<#5XY\_TO
M['(P #XO,]O)[);Q*B#COVR]V W%MM9(H?P]V+[U$5EB-V*=:ZW0A6HM$#.-
M:!2'8Q&D6IX@4JE98WGH9;?V/M=!09PDY\9!7&G%K\Z9U2GM"& %NZ!*6BP
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M%=)-%M+"#QZL8'[C^OX7S/4*D]W@M7?P#7[X2[RR/"N;_[.BEH??^ OVZ\?
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MN84IG5Z:*"NRT%@O9*'2I-Q+K9^A>53SK)XJK]["G*Z8!F[^?:()-AG;0#T
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MR^O-Z_)5#S8PH>/%#.(!O7?0+,TA-M%  HZ$5_# )H$6MX#-[-<-!X!@CX.
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M:-_FW$+.3^32(!&< #@>*1&(LZUP219@QH(N?(]5<W.'6TE[0;B!!]O@C&8
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M]@)H)4$^-#)W'@ ,& 6.$%78X",;&<_&AV:/G#< \%P=YF/H)<=O!=YPB@H
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M6TM.&AF$$(YXSH5GBYO#"W; 7;:.5$OD5+%0[WMWD)YM;@\"LICNG%-\/4X
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MB!62!^JZ^'= ;1^^=AVNB)5J^Y^J^_;_TX\SI-5S/RC9NJ&8\)"U'SJXA1=
M"HQ&7CXX\V@I&"I[GQ TZN86:P8"(H[*;]E)5SA;8D(Q8F]OC#P8LG\N@PUH
M[^C-+*#6EQMK :M\8;D/UF.8W\O*\9*'FT-X^_:>2T&?(J"NO0\K[?V7> 7\
M2L!PW"7.RZ[D-3 (*A(+6>PV@K_8H%<4(\*L??9/SXKG#GS__&QKU8X4#F]\
MU[4"-CP+WN,BMP] &MH4]",8XCC6=@4R,5Q: 06Q$,9N9H;M-N^MK #D;$9G
M ^TPW;25063C2]<A?9'\\!($+@C@QQ>.QY;(;GJ9?QRR\Y869@S(OQ8$.YTH
MNCY%FA6^EWBQ(&>%D?-6N)%_-S0451N6?JTJ6NEW^QZKZ8HQ&K?IL?M?.>D6
M#,;5]OF$-]ZLB_RDL-]SFI)N9E0A2V^O"?R$%=RB?+QW?L"! 99;\D- Q8\@
MK*)ER'^F'IB+ FZ@MVY!IM'5#(2:H0ZJN"9[ ?GD:+4#,5+DL/0686"*4\)1
M11B6R'X$"?[=LO$,KF#VLG25R7=5('S!YW1BZ?V7J%4$0>=SFW55KW1*5 Z!
MMNVS&->PSRI5>(>SC"2*'A%%O4(-\'_A#269]]]_:T[.)=B.TRSG?$6[5E/K
M*PXC2)[V,VTC97X,Z,J)5SNY&H>)DL+$I@;LB9(SCY+-Y79PZ9.%:DL'>WNL
MU=P7]10C; ]]'P#! ]/*ND)])8=#AR;3M8HL2Q3T># UC\P5K(EV#M W4I:U
M8NE3;3 =2EG6#>J['EDV&0X,<]B<+.N-*7E+@WO'WE->K!_JH3:6+U]-H&F#
MD5IS[\_VR+.:"B-:B<YBJ&H#33VR5NOR-DUOF0JDL3&43-47IC(&^NC(85]2
MN>82L>]I&&$""^;;^2MZ-5K6,"92'/1&' REAFV:H29CJ5][PU!3?=HI[6J,
MF]6NQ2SQV8\LEP1/]<>J) DJYP6UAK)*]*X^& UK[J52@Z0X).VJ83'2/4HH
MB?9/!\9T7'/7B'.@JVZEWCT$ED3>QP--LK)D9;#])@-S>-I V_.AJ^M9/IM>
M;?3KFGIAN_)]SD7UW4L$N@@D>A-Y^IEZ=.%$UW.L@\D-T]Z>4U^?BZR; TU7
M9=BIZ;"3/E E6_6'K<;F0)\T&,WMC8+-M_B]'CT['*B3F@<22GG0Y$FO8308
MBY9:EB>Q: -5TR57]86KI@.S8R<\[52R;^@ZH#9OFT,L;TZL%?8D^B_[X&I4
MKC8VI&CHBVC0->G4-LU0ILQ5[ ]#C8P&2YIZEDOA[YR%R*P*D56ARZ-8>10+
MZGLR&(V.-.UE5D4+6'EJ#$9&S0-<)"NWFQ)*LBK,P?#8Q.:.954TPFD'CA>Y
M*BDT;&$)HA1!ES^-T]N:U25-B0I>P<!L8=!>LG$#AVB:>F2YI#0DG@;OKWX8
MXJ2!T'(I]@&?Q2%<$U[/F?M(QO][$Z[\_MN)KNDOY1F Y*D+\E33*/OLK&A(
M/M '\LE?61X L6P:R\G,(Y6F\+XC&M P2B+Y5Z,L,S.=KH&S^ZTMM6-C[5)3
MUA>KDOF>_6&HX734E=/R5JK5WY/Y=JA3R3/>U>?Y@'@TNAH-:TAYT!MY\&RJ
M[XS_E;KU<JPTE<9J;WA)EZJUAO/B&5WX 17]\DAD?:4A2_VF?\9.](B3%4'7
M$M</979:XB2U,)U5GD)=/A'VV-[^\C"Y!4RL#\S12+*Q9&,@A&,+M.5A<@6'
M1W1&>4[6@7_OA%A9QE+4L@;'U;CRSR:C,O>O7=S=2IB6Q*S-!EMG2[]:A#G;
M5ZTA&>I8P[8[M=2M5'EO"SQG\NS5CN#OK31XIDLM5[L=I97"5"JX2QAN$TG2
M=9.T.6Z$I)]0,57?W;ZBX@^TGKDGU2: MX:Z2J*TTPY%:;L2VVDG 92D7DR.
M[/QQ.2Q=+#C;3KR5#0R<CMOG34K6O61(9S"I?92"]$XW1@+ZI,2*HL"9Q9$U
M<RF)?.+Y8#IX4>"[+G8D<41"<R/!V<O;3GWIN<LA=[U.A:SW:0$S]25A\=J9
MJ3.-JUN98+5QQW=T[2_QRO*L_:9F >V<:."U(TKQW4D6=E6FO6RHH7T"KVX[
M."\*CQ=_9R#A1D1C*16?YI@<("9E+.5 6TN*UXZ*U\%TTO]8;ET"5DK7SDE7
M('"UE?*U4T9XR6 V*W1L0JW @Y6&9$T#V,EJA>UMEE:P<U!VJ(XPX,NY'Z-9
MWS,EL7=G;=02RJC5S<'VP;-Q,[P6,NZ<ICB-Q)N)R"C3T[LAUT.*ES3%I9AM
MC9@=*<-6MW-NEYR50K:#0E8SE?&1M<5GEK*=,LB+!<@;QXTC.J_9).^X0FB]
MU&^C<=V\!=TZJJM)?+>''$NMX",;>==Z#ER3G=LZ*NJ9[ *+M2_-1VLS2UM'
M<U<BN="TU!L27:TV'M5*X+M% S$D<0@&I..AV;B.V?RTV?XP+WFF8H1]HFOC
ME^%IA7B5N.<2OLPVQ$JDGZX.]+H'FE9#5G>J<UN+TQ(A C@='CL!H>4YCJU%
M13E[#:<U^T9]8Z]V(K2<MT:J+( _BY:>/Q7[.59/\VV6Q%[[(67&PYJ3#&N0
M,GNAWRH1U%J$ETNA\6C8?0U?2!K]X\UQS6UES\R;9V;/WA@"DR<.VVO3]W]E
ME0'P]]RY_^E'^"-Y0[(D0S%AU6L_='"JYXN NE;DW-.7#\X\6HH59^\3:%<W
MMU@SP -HW]);,LNV*1;_72XTHC.KX29-\N1@R/Z)ZW3F?_O&,4QM.E8M.IU-
MIL,IM2:&K@WG]F*D:]9H.!_]GZ9KWR1W+8,-IN[HS2R@UI<;:P%[>V&Y#]9C
MF(? RO&2)9E#6/,VI#@\?OIQAAC;76EZQ05(E$&,5Y&0]YZMY-=S\96\]CW&
MY19:=S];KN79E-PN*8U"\NR?GA7/'?CF^;E6.4D6R1[TPHG@:KO"LM_XKFL%
M(1JI\!H7Y^4."/UJ4Y1:S!ZU5J!@,S6PV_RYLH([H)J-E 5*X54^>6%HXYO6
M(7V1_/!R[H1KUWI\X7AL7>RFE_G'(<MOA_.02?G7@CQ'4T4=Z4BAPFD0+Q;$
MJS#BW9);_+NQKHQ,L_1K5=%*O]OW6$U75%T_SV.-JH\M,%X2@'N^1\]Y99L=
MN,D)=D7!7D[.0M\" -<[VR!8.?.Y2\\%@F*K[A9$ %W-P#TUU,%ID&C9?HM1
M_H;:;+L<]8969<^234YGDY811TFO;%4W>[7-DD[0JCX\.]DWQ2 U'G56(1J^
MG#FU_<!B[D?L 6W@5=_\]"H,Z9ZV(J>IERRUE88I+OH*22^5N.]U' 0@"HC%
MJ./[;\U)3:+U-"KH/*)YE&7:1HQ;X9*-FK'Q!YPW<V^YU-L5#37$E2YO,YPS
MB:J)E9L#8U)OE/,4*ZO>8\Y+)U(U8:V>.96JB2WI UT_<@;/^<Y(I!8X#(GO
MO7L:1BM4_2&UX\")G#X,!*DF5+718&S4.X:H/5*U1\DCU8"J30:ZUKI#6RF0
M#L/B)VI3L$1G+@U[,F>X8I1G,*JYS8H410V:1F-52J*.2R(^_-S.!4:N11J-
M!].AE$8]D4:CP>C8@NK>2Z-++:/50"C"LC%NH4C^[$>66ZM(;G?#_FK"V@!S
MPZRW"*(&:2U'-ES0WIP.)MJ1%4E-] AMI]QK8]SX8^"O816/[*0&#VG6&*N[
M,L]8'_7UZ./J;%%]8!H7K<"6XJA.]/WJ>W<W$0UP@/@5'QP,AZH42/T02$-Y
MAME=<21F/:]HM/3G&9%T-8)HI-?;6T(*HN:B=,?.W)."J'GD_=WWYP^.ZUZ+
MW)D.1EJ]4T*EY&F,> &9AC2".BM[^#FEFWIFUW52.1RH6KT=L:4D:HR4C8$Q
M:7#J8:LE4?M.%9L7QY5/*IN03/RPLE@:G_5@LBT ./<LM$;4S70P;I_E>_8S
MO&;.5]MB8?5D'EK%@.AH,!R?/N5&GB5WI2#X5\>:.2X[OV&GS+>1;W]9^BY<
M$(IF@(0'6FLK&BX;SE&E6/0\4V Z6V#:NARMI)+8W9#5A<N)3W"1.DL&[4VC
M_IEZ=.%$(5E;CUC6(<N+6VC6:NI E?7%G2"]JZDO!IH<#H\<S'MMYF9[Q?_G
MP)I38MDVZ^27* %F:,*'08S]J+^NJ1=>3_:0.3#;%T*0(>OC@&H.=+/!?O52
M2-5BH_K^%^+#*N:!M;B:Q&I#[:O%=W52:*C*8[..RZ!_>CB7 \RA@-Y3+[X>
M<T@?U3M:0XJAYJH[1M)?Z[@8NEWZ0<03B>9T=C6V$#OHT%]*0=0/062.93)U
M5U)^6B*-.]#P('.D)KL>:*.!-FE=&9[L>G#! X+18&K(3)4>IK1ORHROR0;5
M],%(E;GL/3%!-6V@#643P -S=#H@G+;K;6JSRMI(VV4M60RS=::7%%1'"JK!
MU)3E?UWQ;)LW&-O@+>^KN)%><O:,%ZP0HW4VI?22+X<(0QVHQI%VJ/22VYMF
M[Z]6#F]VPZ<XP1VP7NK9^^3>::/7+EBGT;?\_-;13U&5#V55/K):XXJ/?S\&
M=$&#@*)N  (9D.\TLK8"H(GI2X)5 BK[G\_G!LD31TL_@,?/!P3!09PPC.G\
M6OQ@>6K<*T]8H%/ZPN<^-]#_7WM?_MRVD27\KW0E,_GD+1#!?4@95SEV$FMW
M/=9:DTWM3U--H"5B#0)< )2C^>N_;@"4*(H P0OH;KR9'5DK7-WO?J_?8;'_
MGL<H2I,GT:6INH.,'[ZWW"OS68J96HL8JP6=[[$R?\4T]%JB(5R@%U/)4>M8
M9LGDG E=!B41<2;D"0MNH;W'BXB%N:($D3\#DN<HO6/"#3W@>/FJNE9:B:0X
M)M10R2*4%,L!N22X7/I""ARQ^@56QD!7/)[#4%_Q^4M$ UET8 F#IY@Z) \+
M+HS>!<%ROHQQ0>516LUQ3.>+C,Q(DD</!,5I/AKY=.$XSAN0$B>EKPM=T1RW
M":H@((X]]3A7@.@?&<'Y,GM<A8AP07>1%PIR/<6R',6PS:>8T)@#/A>Z16UR
M"\3&J<6&I9BN#G)#\!2CO/'P%#*.=$^Q#9A&.N*,(]VA0@ZFD4KK7/T]35BV
M49;&]-H]BI*"4(-I/",G' CV2&*/N="N0@I[#&RO9]O+ ]MKW+:798'M)?]<
MF7BC:_]V$7A6L<<+0&#.C#22?!CIS4ME,<R9 4W58Q;NN637!S(M*&[H_Y7-
MBZI\M>A?Y> 95,Z?Z6ZI5^MOX/4#9[WP9,4U2']-Y2[CM@M"=D'] ([L$>I_
M[4*6YQD_Q!-)-HAK73U>6(M &]NWWTP; VF('PLV1X'^&T8/;W^B/U9/U,LV
M';JO19I'Y;BOC,14[CZ0JV]16,SJ/:T_5;.U]OP(GE(27A;-CZRA*2 L!GPJ
MC.CZ+I08907CY/DXO@3"^D^VSBC\VW>1:>N^JV'B3SW?\@GV3$.WPN#.,73L
M6*'S3]VPOEL]-<N>U>P]F4PS@K].\!W=VR6.O^''_"4$YE&R6I*IJS9=]2:L
M*HB\_6G*,/9ZK4]W' \SK1/,/B[G.,'H.@E4]')!O2_E?9J4,K+,T;HMZ#]5
M,7-ZA][C?(9^C=-O.;KX/<'+,*+WO$$GU8CN:I'EBRY+$R7HL.P/:1SC+&?I
M]_0S,>64_&EA)4MNZ,N W;_(R>7JEZL52T=)^?;RH:LYSNXI-=5LR$AI,[+*
MN*VZ7%.92R6RZS-"JZW%^L,U#:HE#6X(Z>J:XZBN:S1>UE2]\5K;:W5+]1WS
M/*^UN[YV:+F\VW)OK%IV-HW?W?[-U2LAS(,A]6N:5:9",2,HH9?1G#XSRQ%)
M0L;L3VE5+*^*-\4JB.NUCP6_WU[XH:/6C+OCFLEQM4D+>."$ "VMA[O2>KC+
MTCE*%X0%'9)[A -J [<WANJQ00KT0>%$:/Z=%-2<"](YS";E,2RC*]3,Y2T:
M=N+S#J$(;+_#"YX(K*D!IN>W5WS!J<+P6'H7_N\RKQN>%2G*2) F043][>1)
M?+._L_\O8!; (DL?(N9N3!^WF@ ]M[F2N)L5C]3RGREKC)"@'%,*2>_0=)G3
M>\93].=P=WYTQEPOL1!V>.\I4$/#X^DW'"5,L$3) ZG4$<I)L,Q*G:(P]3,6
M$7,Q2%FQ6)!K*@/4^H(<L/C^Z/FE3*5D)SS,F&2M L8SV<$;TTAHL1#6-.D0
M3 ;.Y4G9:GDRQ3D)RS8D),G+7+BQR!3=!V>$5XPU1,3L]G9L(%6&Q]$'LLA(
M$(U*DM@>=Z-,0)*TPL[Q#) DG$N2=_.4KN%?HY(D%I@DO"*LJ5P(Y CG<N1Z
MOL!15H9$64OJC)VZ%8]/U:D+=F4L\D6W0+YPBK &E\=H+V\! 3,\CEX*F"@)
MR5V41 69Q-$#"5DC(IS<1RP''^<Y&4]#(I.[EA\@;."P=Y? X6\.+DC=K?G4
M,RI525GQM)9'50K8TK9;ZT12GG\SV4SN[DA0K"?>L#8E ;4"V6@Y]A2#59J7
M Y<@#4M:VOE" A(]L JWT2ACW0%ES"G"&K,Q?$C'X%>&?"[G-XS+HK_0%=,=
MHOVZ6,!K&.%B>^.VK 5@ZI])0IUW:D$N\",S#T;#V*;=V/X?V+J59#S/ K;F
MG*TK7;WF$8Z%KW4V-0P,?TYQUF#X6[X'AC^_PN3WA(V2)"'*R -)EN,1)C8(
M$D[QU2!(FD<Z@1P9'CVE43(6V6& %<(KPAIFD$!BT^NQ1^;0DF0[<_V]:W.!
M,XTBX96R&T218KO<I5EVAFUOHDHX;&^'NJE8?GN IE?0\R[G>!1OFYW3JAIW
M*3JG[?D)H)FN;'^3I0$A84TQF^U61M400=?!<><58Y"')[*0><<RQZJ^],\Y
M9J4ASE+)RE]8A<$#E3ZL/=@JT6PL@N?"AB/%PP)WICO:P!U_J;( !%  35;F
M,@MFF"41-U:6C<K4O# MR X[]-37@-,:CEE]K=S@N;$>HH8=6SC;4XP+DN&8
M=8"M<\M'P_6Z!<ECAUIZ#G ]QUS_0L%O[:TY&B:W%;V_O"1A@=? YHZB608P
M.K^,_@D7*YT^=DXW%-V"=IN\XJRAMD0Q=$A#YUW(O#Z4 FEC*YH#I:F\XJQI
M,HT[]EHV_J*IPXM<\7+D+I9YV:#GS7XY)<?E3W')Z$WE0XZE\R:<.T^A'3A/
MCDL\-_BGAN)YC=T&^@,X[Q*.1\&VF1UW%R4X":3(CH/4N+-X(?BQ&E=7DDM
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MW1=P=/ &A)$P&9GB@J ['!1I-C;A<J'WIPB%!1TTI!.9T\N6\E4GNM%PM>L
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M-2+\$]F1F^:3^BYTVQ&Z' ;$&]\$9O'<[X6_\EM1[@3  F#%NA, "X 5ZTX
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M8"Y6OHIR/Q4FC\3A,G0+3$8^40,6/: 'T".D8)-&0:[5\+Z[_3P2G:BW6U#
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M1$W"F$1 ]IR3O7-@?AN(4*"E5RW%=(WCEF+\E=S#G=## NX$ H [@0#@3B
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MY@UW8VA3<0U_/"PMMTMD4'L<G**A@PR:XMKNB%A*+*0U!!,HSMKCXUPP"(\
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MGUDQC]_^?U!+ 0(4 Q0    ( &<Q95L+52SX$",  "8G 0 >
M  "  0    !A,W$R,#(U:'5M86YA:6YC<&]S=&5D<F5M82YH=&U02P$"% ,4
M    " !G,65;(F,DY?P/  "H=0  $               @ %,(P  :'5M+3(P
M,C4Q,3 U+FAT;5!+ 0(4 Q0    ( &<Q95N7:Q\=80(  /T&   0
M      "  78S  !H=6TM,C R-3$Q,#4N>'-D4$L! A0#%     @ 9S%E6W)P
M[5,B"@  ?54  !0              ( !!38  &AU;2TR,#(U,3$P-5]L86(N
M>&UL4$L! A0#%     @ 9S%E6]>RT"^P!@  Y3   !0              ( !
M64   &AU;2TR,#(U,3$P-5]P<F4N>&UL4$L! A0#%     @ 9S%E6X2I6INP
M-P  @P<# !P              ( !.T<  &AU;2TR,#(U<3,X:WAE>#DY>#%B
M<FEE9BYH=&U02P$"% ,4    " !G,65;YJC2NG"T  "+J@X 'P
M    @ $E?P  :'5M+3(P,C5Q,SAK>&5X.3EX,F1E=&%I;&5D+FAT;5!+!08
1    !P ' .,!  #2,P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>hum-20251105_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20251105.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2025-11-05</startDate>
            <endDate>2025-11-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000049071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-11-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Humana Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-5975</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">500 West Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">580-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
